| 226 Einträge |
| Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma. | |
| Autoren | Laszlo V, Hoda MA, Garay T, Pirker C, Ghanim B, Klikovits T, Dong YW, Rozsas A, Kenessey I, Szirtes I, Grusch M, Jakopovic M, Samarzija M, Brcic L, Kern I, Rozman A, Popper H, Zöchbauer-Müller S, Heller G, Altenberger C, Ziegler B, Klepetko W, Berger W, Dome B, Hegedus B |
| Erscheinungsdaten | The Journal of pathology. 2015 May 26. doi: 10.1002/path.4567 |
| Publikations ID | PMID: 26011651 |
| Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance. | |
| Autoren | Miklos W, Pelivan K, Kowol CR, Pirker C, Dornetshuber-Fleiss R, Spitzwieser M, Englinger B, van Schoonhoven S, Cichna-Markl M, Koellensperger G, Keppler BK, Berger W, Heffeter P |
| Erscheinungsdaten | Cancer letters. 2015 Mar 5. pii: S0304-3835(15)00164-0. doi: 10.1016/j.canlet.2015.02.049 |
| Publikations ID | PMID: 25749419 |
| Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis. | |
| Autoren | Spiegl-Kreinecker S, Lötsch D, Ghanim B, Pirker C, Mohr T, Laaber M, Weis S, Olschowski A, Webersinke G, Pichler J, Berger W |
| Erscheinungsdaten | Neuro-oncology. 2015 Feb 13. pii: nov010. doi: 10.1093/neuonc/nov010 |
| Publikations ID | PMID: 25681309 |
| Vemurafenib resistance signature by proteome analysis offers new strategies and rational therapeutic concepts. | |
| Autoren | Paulitschke V, Berger W, Paulitschke P, Hofstätter E, Knapp B, Dingelmaier-Hovorka R, Födinger D, Jäger W, Szekeres T, Meshcheryakova A, Bileck A, Pirker C, Pehamberger H, Gerner C, Kunstfeld R |
| Erscheinungsdaten | Molecular cancer therapeutics. 2015 Jan 22. pii: 1535-7163.MCT-14-0701. doi: 10.1158/1535-7163.MCT-14-0701 |
| Publikations ID | PMID: 25612618 |
| Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma. | |
| Autoren | Gauglhofer C, Paur J, Schrottmaier WC, Wingelhofer B, Huber D, Naegelen I, Pirker C, Mohr T, Heinzle C, Holzmann K, Marian B, Schulte-Hermann R, Berger W, Krupitza G, Grusch M, Grasl-Kraupp B |
| Erscheinungsdaten | Carcinogenesis. 2014 Jul 16. pii: bgu151. doi: 10.1093/carcin/bgu151 |
| Publikations ID | PMID: 25031272 |
| Impact of terminal dimethylation on the resistance profile of α-N-heterocyclic thiosemicarbazones. | |
| Autoren | Heffeter P, Pirker C, Kowol CR, Herrman G, Dornetshuber R, Miklos W, Jungwirth U, Koellensperger G, Keppler BK, Berger W |
| Erscheinungsdaten | Biochemical pharmacology. 2012 Mar 15. pii: S0006-2952(12)00196-7. doi: 10.1016/j.bcp.2012.03.004. pmc: PMC3342514 |
| Publikations ID | PMID: 22426010 |
| Synergistic effects of erlotinib and everolimus on bronchial carcinoids and large-cell neuroendocrine carcinomas with activated EGFR/AKT/mTOR pathway. | |
| Autoren | Bago-Horvath Z, Sieghart W, Grusch M, Lackner A, Hayden H, Pirker C, Komina O, Węsierska-Gądek J, Haitel A, Filipits M, Berger W, Schmid K |
| Erscheinungsdaten | Neuroendocrinology. 2012 Apr 27. pii: 000337257. doi: 10.1159/000337257 |
| Publikations ID | PMID: 22378048 |
| Fibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition. | |
| Autoren | Metzner T, Bedeir A, Held G, Peter-Vörösmarty B, Ghassemi S, Heinzle C, Spiegl-Kreinecker S, Marian B, Holzmann K, Grasl-Kraupp B, Pirker C, Micksche M, Berger W, Heffeter P, Grusch M |
| Erscheinungsdaten | The Journal of investigative dermatology. 2011 Jul 14. pii: jid2011177. doi: 10.1038/jid.2011.177. pmc: PMC3383623. mid: UKMS48843 |
| Publikations ID | PMID: 21753785 |
| DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies. | |
| Autoren | Schmidt WM, Uddin MH, Dysek S, Moser-Thier K, Pirker C, Höger H, Ambros IM, Ambros PF, Berger W, Bittner RE |
| Erscheinungsdaten | PLoS genetics. 2011 Apr 14. doi: 10.1371/journal.pgen.1002042. pmc: PMC3077392 |
| Publikations ID | PMID: 21533183 |
| Overexpression of Aurora-A in primary cells interferes with S-phase entry by diminishing Cyclin D1 dependent activities. | |
| Autoren | Jantscher F, Pirker C, Mayer CE, Berger W, Sutterluety H |
| Erscheinungsdaten | Molecular cancer. 2011 Mar 16. pii: 1476-4598-10-28. doi: 10.1186/1476-4598-10-28. pmc: PMC3068985 |
| Publikations ID | PMID: 21410931 |
| A human model of epithelial to mesenchymal transition to monitor drug efficacy in hepatocellular carcinoma progression. | |
| Autoren | van Zijl F, Mall S, Machat G, Pirker C, Zeillinger R, Weinhaeusel A, Bilban M, Berger W, Mikulits W |
| Erscheinungsdaten | Molecular cancer therapeutics. 2011 Mar 1. pii: 1535-7163.MCT-10-0917. doi: 10.1158/1535-7163.MCT-10-0917 |
| Publikations ID | PMID: 21364009 |
| Response of experimental malignant melanoma models to the pan-Aurora kinase inhibitor VE-465. | |
| Autoren | Pirker C, Lötsch D, Spiegl-Kreinecker S, Jantscher F, Sutterlüty H, Micksche M, Grusch M, Berger W |
| Erscheinungsdaten | Experimental dermatology. 2010 Nov 22. doi: 10.1111/j.1600-0625.2010.01182.x |
| Publikations ID | PMID: 21087322 |
| EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases. | |
| Autoren | Schmid K, Oehl N, Wrba F, Pirker R, Pirker C, Filipits M |
| Erscheinungsdaten | Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Jul 7. pii: 1078-0432.CCR-09-0089. doi: 10.1158/1078-0432.CCR-09-0089 |
| Publikations ID | PMID: 19584155 |
| Simultaneous blockade of the epidermal growth factor receptor/mammalian target of rapamycin pathway by epidermal growth factor receptor inhibitors and rapamycin results in reduced cell growth and survival in biliary tract cancer cells. | |
| Autoren | Herberger B, Berger W, Puhalla H, Schmid K, Novak S, Brandstetter A, Pirker C, Gruenberger T, Filipits M |
| Erscheinungsdaten | Molecular cancer therapeutics. 2009 Jun 9. pii: 1535-7163.MCT-09-0003. doi: 10.1158/1535-7163.MCT-09-0003 |
| Publikations ID | PMID: 19509244 |
| Synergistic effect of Sorafenib and Sunitinib with Enzastaurin, a selective protein kinase C inhibitor in renal cell carcinoma cell lines. | |
| Autoren | Vogl UM, Berger W, Micksche M, Pirker C, Lamm W, Pichelmeyer O, Zielinski CC, Schmidinger M |
| Erscheinungsdaten | Cancer letters. 2009 Jan 25. pii: S0304-3835(08)00945-2. doi: 10.1016/j.canlet.2008.12.013 |
| Publikations ID | PMID: 19171421 |
| Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24). | |
| Autoren | Heffeter P, Jakupec MA, Körner W, Chiba P, Pirker C, Dornetshuber R, Elbling L, Sutterlüty H, Micksche M, Keppler BK, Berger W |
| Erscheinungsdaten | Biochemical pharmacology. 2007 Mar 12. pii: S0006-2952(07)00146-3. doi: 10.1016/j.bcp.2007.03.002. pmc: PMC3371634. mid: UKMS48675 |
| Publikations ID | PMID: 17445775 |
| Malignant predominantly minigemistocytic glioma in two infants: a distinctive glioma variant? | |
| Autoren | Haberler C, Slavc I, Czech T, Prayer D, Pirker C, Budka H, Hainfellner JA |
| Erscheinungsdaten | Neuropathology and applied neurobiology. 2007 Mar 15. pii: NAN823. doi: 10.1111/j.1365-2990.2006.00823.x |
| Publikations ID | PMID: 17359358 |
| Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT. | |
| Autoren | Brachner A, Sasgary S, Pirker C, Rodgarkia C, Mikula M, Mikulits W, Bergmeister H, Setinek U, Wieser M, Chin SF, Caldas C, Micksche M, Cerni C, Berger W |
| Erscheinungsdaten | Cancer research. 2006 Apr 4. pii: 66/7/3584. doi: 10.1158/0008-5472.CAN-05-2839 |
| Publikations ID | PMID: 16585183 |
| The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals. | |
| Autoren | Steiner E, Holzmann K, Pirker C, Elbling L, Micksche M, Sutterlüty H, Berger W |
| Erscheinungsdaten | Journal of cell science. 2006 Jan 17. pii: jcs.02773. doi: 10.1242/jcs.02773 |
| Publikations ID | PMID: 16418217 |
| Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma. | |
| Autoren | Okamoto I, Pirker C, Bilban M, Berger W, Losert D, Marosi C, Haas OA, Wolff K, Pehamberger H |
| Erscheinungsdaten | Neoplasia (New York, N.Y.). 2005 Jun 21. pmc: PMC1501156 |
| Publikations ID | PMID: 15967107 |
| EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance. | |
| Autoren | Sevelda F, Mayr L, Kubista B, Lötsch D, van Schoonhoven S, Windhager R, Pirker C, Micksche M, Berger W |
| Erscheinungsdaten | Journal of experimental & clinical cancer research : CR. 2015 Nov 2. doi: 10.1186/s13046-015-0251-5. pii: 10.1186/s13046-015-0251-5. pmc: PMC4630894 |
| Publikations ID | PMID: 26526352 |
| Opposing roles of JNK and p38 in lymphangiogenesis in melanoma. | |
| Autoren | Puujalka E, Heinz M, Hoesel B, Friedl P, Schweighofer B, Wenzina J, Pirker C, Schmid JA, Loewe R, Wagner EF, Berger W, Petzelbauer P |
| Erscheinungsdaten | The Journal of investigative dermatology. 2016 Jan 29. pii: S0022-202X(16)00374-2. doi: 10.1016/j.jid.2016.01.020 |
| Publikations ID | PMID: 26829032 |
| Chronic arsenic trioxide exposure leads to enhanced aggressiveness via Met oncogene addiction in cancer cells. | |
| Autoren | Kryeziu K, Pirker C, Englinger B, van Schoonhoven S, Spitzwieser M, Mohr T, Körner W, Weinmüllner R, Tav K, Grillari J, Cichna-Markl M, Berger W, Heffeter P |
| Erscheinungsdaten | Oncotarget. 2016 Mar 28. pii: 8415. doi: 10.18632/oncotarget.8415 |
| Publikations ID | PMID: 27036042 |
| Anticancer metal drugs and immunogenic cell death. | |
| Autoren | Terenzi A, Pirker C, Keppler BK, Berger W |
| Erscheinungsdaten | Journal of inorganic biochemistry. 2016 Jun 16. pii: S0162-0134(16)30184-2. doi: 10.1016/j.jinorgbio.2016.06.021 |
| Publikations ID | PMID: 27350082 |
| Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expression. | |
| Autoren | Englinger B, Lötsch D, Pirker C, Mohr T, van Schoonhoven S, Boidol B, Lardeau CH, Spitzwieser M, Szabó P, Heffeter P, Lang I, Cichna-Markl M, Grasl-Kraupp B, Marian B, Grusch M, Kubicek S, Szakács G, Berger W |
| Erscheinungsdaten | Oncotarget. 2016 Jun 29. pii: 10324. doi: 10.18632/oncotarget.10324 |
| Publikations ID | PMID: 27367030 |
| Trabectedin is active against malignant pleural mesothelioma cell and xenograft models and synergizes with chemotherapy and bcl-2 inhibition in vitro. | |
| Autoren | Hoda MA, Pirker C, Dong Y, Schelch K, Heffeter P, Kryeziu K, van Schoonhoven S, Klikovits T, Laszlo V, Rozsas A, Ozsvar J, Klepetko W, Doeme B, Grusch M, Hegedues B, Berger W |
| Erscheinungsdaten | Molecular cancer therapeutics. 2016 Aug 10. pii: 1535-7163.MCT-15-0846. doi: 10.1158/1535-7163.MCT-15-0846 |
| Publikations ID | PMID: 27512118 |
| Loss of phosphodiesterase 4D mediates acquired triapine resistance via Epac-Rap1-Integrin signaling. | |
| Autoren | Miklos W, Heffeter P, Pirker C, Hager S, Kowol CR, Schoonhoven SV, Stojanovic M, Keppler BK, Berger W |
| Erscheinungsdaten | Oncotarget. 2016 Sep 2. pii: 11821. doi: 10.18632/oncotarget.11821 |
| Publikations ID | PMID: 27602951 |
| Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients. | |
| Autoren | Spitzwieser M, Pirker C, Koblmüller B, Pfeiler G, Hacker S, Berger W, Heffeter P, Cichna-Markl M |
| Erscheinungsdaten | Oncotarget. 2016 Sep 28. pii: 12332. doi: 10.18632/oncotarget.12332 |
| Publikations ID | PMID: 27689338 |
| Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance. | |
| Autoren | Englinger B, Mair M, Miklos W, Pirker C, Mohr T, van Schoonhoven S, Lötsch D, Körner W, Ferk F, Knasmüller S, Heffeter P, Keppler BK, Grusch M, Berger W |
| Erscheinungsdaten | British journal of cancer. 2017 Jan 17. pii: bjc2016449. doi: 10.1038/bjc.2016.449 |
| Publikations ID | PMID: 28095394 |
| [(11)C]Erlotinib PET cannot detect acquired erlotinib resistance in NSCLC tumor xenografts in mice. | |
| Autoren | Traxl A, Beikbaghban T, Wanek T, Kryeziu K, Pirker C, Mairinger S, Stanek J, Filip T, Sauberer M, Kuntner C, Berger W, Langer O |
| Erscheinungsdaten | Nuclear medicine and biology. 2017 May 25. pii: S0969-8051(17)30117-8. doi: 10.1016/j.nucmedbio.2017.05.007 |
| Publikations ID | PMID: 28575795 |
| Sensitivity towards the GRP78 inhibitor KP1339/IT-139 is characterized by apoptosis induction via caspase 8 upon disruption of ER homeostasis. | |
| Autoren | Schoenhacker-Alte B, Mohr T, Pirker C, Kryeziu K, Kuhn PS, Buck A, Hofmann T, Gerner C, Hermann G, Koellensperger G, Keppler BK, Berger W, Heffeter P |
| Erscheinungsdaten | Cancer letters. 2017 Jul 14. pii: S0304-3835(17)30435-4. doi: 10.1016/j.canlet.2017.07.009 |
| Publikations ID | PMID: 28716523 |
| Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer. | |
| Autoren | Englinger B, Kallus S, Senkiv J, Heilos D, Gabler L, van Schoonhoven S, Terenzi A, Moser P, Pirker C, Timelthaler G, Jäger W, Kowol CR, Heffeter P, Grusch M, Berger W |
| Erscheinungsdaten | Journal of experimental & clinical cancer research : CR. 2017 Sep 7. doi: 10.1186/s13046-017-0592-3. pii: 10.1186/s13046-017-0592-3 |
| Publikations ID | PMID: 28882160 |
| Intrathoracic solitary fibrous tumor - an international multicenter study on clinical outcome and novel circulating biomarkers. | |
| Autoren | Ghanim B, Hess S, Bertoglio P, Celik A, Bas A, Oberndorfer F, Melfi F, Mussi A, Klepetko W, Pirker C, Berger W, Harmati I, Farkas A, Jan Ankersmit H, Dome B, Fillinger J, Aigner C, Hegedus B, Renyi-Vamos F, Lang G |
| Erscheinungsdaten | Scientific reports. 2017 Oct 2. doi: 10.1038/s41598-017-12914-2. pii: 10.1038/s41598-017-12914-2 |
| Publikations ID | PMID: 28970578 |
| Dysregulated expression of the microRNA miR-137 and its target YB-1 contribute to the invasive characteristics of malignant pleural mesothelioma. | |
| Autoren | Johnson TG, Schelch K, Cheng YY, Williams M, Sarun KH, Kirschner MB, Kao S, Linton A, Klebe S, McCaughan BC, Lin RC, Pirker C, Berger W, Lasham A, van Zandwijk N, Reid G |
| Erscheinungsdaten | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2017 Nov 4. pii: S1556-0864(17)32860-5. doi: 10.1016/j.jtho.2017.10.016 |
| Publikations ID | PMID: 29113949 |
| FGF5 is expressed in melanoma and enhances malignancy in vitro and in vivo. | |
| Autoren | Ghassemi S, Vejdovszky K, Sahin E, Ratzinger L, Schelch K, Mohr T, Peter-Vörösmarty B, Brankovic J, Lackner A, Leopoldi A, Meindl D, Pirker C, Hegedus B, Marian B, Holzmann K, Grasl-Kraupp B, Heffeter P, Berger W, Grusch M |
| Erscheinungsdaten | Oncotarget. 2017 Sep 23. doi: 10.18632/oncotarget.21184. pii: 21184. pmc: PMC5675669 |
| Publikations ID | PMID: 29152117 |
| CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model. | |
| Autoren | Mayr L, Pirker C, Lötsch D, Van Schoonhoven S, Windhager R, Englinger B, Berger W, Kubista B |
| Erscheinungsdaten | Oncotarget. 2017 Dec 9. doi: 10.18632/oncotarget.23125. pii: 23125. pmc: PMC5768389 |
| Publikations ID | PMID: 29371972 |
| Dynamics of CRISPR/Cas9-mediated genomic editing of the AXL locus in hepatocellular carcinoma cells. | |
| Autoren | Scharf I, Bierbaumer L, Huber H, Wittmann P, Haider C, Pirker C, Berger W, Mikulits W |
| Erscheinungsdaten | Oncology letters. 2017 Dec 13. doi: 10.3892/ol.2017.7605. pii: OL-0-0-7605. pmc: PMC5777348 |
| Publikations ID | PMID: 29434956 |
| FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal. | |
| Autoren | Schelch K, Wagner C, Hager S, Pirker C, Siess K, Lang E, Lin R, Kirschner MB, Mohr T, Brcic L, Marian B, Holzmann K, Grasl-Kraupp B, Krupitza G, Laszlo V, Klikovits T, Dome B, Hegedus B, Garay T, Reid G, van Zandwijk N, Klepetko W, Berger W, Grusch M, Hoda MA |
| Erscheinungsdaten | Carcinogenesis. pii: 4904272. doi: 10.1093/carcin/bgy018 |
| Publikations ID | PMID: 29635378 |
| Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis. | |
| Autoren | Groza D, Gehrig S, Kudela P, Holcmann M, Pirker C, Dinhof C, Schueffl HH, Sramko M, Hoebart J, Alioglu F, Grusch M, Ogris M, Lubitz W, Keppler BK, Pashkunova-Martic I, Kowol CR, Sibilia M, Berger W, Heffeter P |
| Erscheinungsdaten | Oncoimmunology. 2018 Feb 16. doi: 10.1080/2162402X.2018.1424676. pii: 1424676. pmc: PMC5927527 |
| Publikations ID | PMID: 29721389 |
| Nintedanib is active in malignant pleural mesothelioma cell models and inhibits angiogenesis and tumor growth in vivo. | |
| Autoren | Laszlo V, Valko Z, Kovacs I, Ozsvar J, Hoda MA, Klikovits T, Lakatos D, Czirók A, Garay T, Stiglbauer A, Helbich TH, Groger M, Tovari J, Klepetko W, Pirker C, Grusch M, Berger W, Hilberg F, Hegedus B, Dome B |
| Erscheinungsdaten | Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 May 3. pii: 1078-0432.CCR-17-1507. doi: 10.1158/1078-0432.CCR-17-1507 |
| Publikations ID | PMID: 29724868 |
| Altered membrane rigidity via enhanced endogenous cholesterol synthesis drives cancer cell resistance to destruxins. | |
| Autoren | Heilos D, Röhrl C, Pirker C, Englinger B, Baier D, Mohr T, Schwaiger M, Iqbal SM, van Schoonhoven S, Klavins K, Eberhart T, Windberger U, Taibon J, Sturm S, Stuppner H, Koellensperger G, Dornetshuber-Fleiss R, Jäger W, Lemmens-Gruber R, Berger W |
| Erscheinungsdaten | Oncotarget. 2018 May 22. doi: 10.18632/oncotarget.25432. pii: 25432. pmc: PMC5986646 |
| Publikations ID | PMID: 29876015 |
| TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma. | |
| Autoren | Spiegl-Kreinecker S, Lötsch D, Neumayer K, Kastler L, Gojo J, Pirker C, Pichler J, Weis S, Kumar R, Webersinke G, Gruber A, Berger W |
| Erscheinungsdaten | Neuro-oncology. 2018 Jul 11. pii: 5052146. doi: 10.1093/neuonc/noy104 |
| Publikations ID | PMID: 30010853 |
| Metal Drugs and the Anticancer Immune Response. | |
| Autoren | Englinger B, Pirker C, Heffeter P, Terenzi A, Kowol CR, Keppler BK, Berger W |
| Erscheinungsdaten | Chemical reviews. 2018 Nov 29. doi: 10.1021/acs.chemrev.8b00396 |
| Publikations ID | PMID: 30489072 |
| Subcellular Duplex DNA and G-Quadruplex Interaction Profiling of a Hexagonal Pt Metallacycle. | |
| Autoren | Domarco O, Kieler C, Pirker C, Dinhof C, Englinger B, Reisecker JM, Timelthaler G, García MD, Peinador C, Keppler BK, Berger W, Terenzi A |
| Erscheinungsdaten | Angewandte Chemie (International ed. in English). 2019 Apr 19. doi: 10.1002/anie.201900934 |
| Publikations ID | PMID: 31002438 |
| TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF/TERT promoter double-mutated glioma. | |
| Autoren | Gabler L, Lötsch D, Kirchhofer D, van Schoonhoven S, Schmidt HM, Mayr L, Pirker C, Neumayer K, Dinhof C, Kastler L, Azizi AA, Dorfer C, Czech T, Haberler C, Peyrl A, Kumar R, Slavc I, Spiegl-Kreinecker S, Gojo J, Berger W |
| Erscheinungsdaten | Acta neuropathologica communications. 2019 Aug 7. doi: 10.1186/s40478-019-0775-6. pii: 10.1186/s40478-019-0775-6 |
| Publikations ID | PMID: 31391125 |
| Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity. | |
| Autoren | Vlacic G, Hoda MA, Klikovits T, Sinn K, Gschwandtner E, Mohorcic K, Schelch K, Pirker C, Peter-Vörösmarty B, Brankovic J, Dome B, Laszlo V, Cufer T, Rozman A, Klepetko W, Grasl-Kraupp B, Hegedus B, Berger W, Kern I, Grusch M |
| Erscheinungsdaten | Cells. 2019 Sep 16. pii: cells8091091. doi: 10.3390/cells8091091 |
| Publikations ID | PMID: 31527449 |
| Combined MEK and PI3K/p110b inhibition as a novel targeted therapy for malignant mesothelioma displaying sarcomatoid features. | |
| Autoren | Marqués M, Tranchant R, Risa-Ebrí B, Suárez-Solís ML, Fernández LC, Carrillo-de-Santa-Pau E, Del Pozo N, Martínez de Villarreal J, Meiller C, Allory Y, Blum Y, Pirker C, Hegedus B, Barry ST, Carnero A, Berger W, Jean D, Real FX |
| Erscheinungsdaten | Cancer research. 2020 Jan 7. pii: 0008-5472.CAN-19-1633. doi: 10.1158/0008-5472.CAN-19-1633 |
| Publikations ID | PMID: 31911549 |
| Lipid Droplet-Mediated Scavenging As Novel Intrinsic And Adaptive Resistance Factor Against The Multikinase Inhibitor Ponatinib. | |
| Autoren | Englinger B, Laemmerer A, Moser P, Kallus S, Röhrl C, Pirker C, Baier D, Mohr T, Niederstaetter L, Meier-Menches SM, Gerner C, Gabler L, Gojo J, Timelthaler G, Senkiv J, Jäger W, Kowol CR, Heffeter P, Berger W |
| Erscheinungsdaten | International journal of cancer. 2020 Feb 16. doi: 10.1002/ijc.32924 |
| Publikations ID | PMID: 32064608 |
| Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma. | |
| Autoren | Bilecz A, Stockhammer P, Theegarten D, Kern I, Jakopovic M, Samarzija M, Klikovits T, Hoda MA, Döme B, Oberndorfer F, Muellauer L, Fillinger J, Kovács I, Pirker C, Schuler M, Plönes T, Aigner C, Klepetko W, Berger W, Brcic L, Laszlo V, Hegedus B |
| Erscheinungsdaten | Histopathology. 2020 Mar 14. doi: 10.1111/his.14105 |
| Publikations ID | PMID: 32170970 |
| I Radiolabeling of a Au -NHC Complex for In Vivo Biodistribution Studies. | |
| Autoren | Guarra F, Terenzi A, Pirker C, Passannante R, Baier D, Zangrando E, Gómez-Vallejo V, Biver T, Gabbiani C, Berger W, Llop J, Salassa L |
| Erscheinungsdaten | Angewandte Chemie (International ed. in English). 2020 Jul 7. doi: 10.1002/anie.202008046 |
| Publikations ID | PMID: 32633820 |
| Homeopathic Treatment as an 'Add on' Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Three-Arm, Multicenter Study. | |
| Autoren | Frass M, Lechleitner P, Gründling C, Pirker C, Grasmuk-Siegl E, Domayer J, Hochmayr M, Gaertner K, Duscheck C, Muchitsch I, Marosi C, Schumacher M, Zöchbauer-Müller S, Manchanda RK, Schrott A, Burghuber O |
| Erscheinungsdaten | The oncologist. 2020 Oct 3. doi: 10.1002/onco.13548 |
| Publikations ID | PMID: 33010094 |
| p53 Loss Mediates Hypersensitivity to ETS Transcription Factor Inhibition Based on PARylation-Mediated Cell Death Induction. | |
| Autoren | Dinhof C, Pirker C, Kroiss P, Kirchhofer D, Gabler L, Gojo J, Lötsch-Gojo D, Stojanovic M, Timelthaler G, Ferk F, Knasmüller S, Reisecker J, Spiegl-Kreinecker S, Birner P, Preusser M, Berger W |
| Erscheinungsdaten | Cancers. 2020 Oct 30. pii: cancers12113205. doi: 10.3390/cancers12113205 |
| Publikations ID | PMID: 33143299 |
| Targeting fibroblast growth factor receptors to combat aggressive ependymoma. | |
| Autoren | Lötsch D, Kirchhofer D, Englinger B, Jiang L, Okonechnikov K, Senfter D, Laemmerer A, Gabler L, Pirker C, Donson AM, Bannauer P, Korbel P, Jaunecker CN, Hübner JM, Mayr L, Madlener S, Schmook MT, Ricken G, Maaß K, Grusch M, Holzmann K, Grasl-Kraupp B, Spiegl-Kreinecker S, Hsu J, Dorfer C, Rössler K, Azizi AA, Foreman NK, Peyrl A, Haberler C, Czech T, Slavc I, Filbin MG, Pajtler KW, Kool M, Berger W, Gojo J |
| Erscheinungsdaten | Acta neuropathologica. 2021 May 27. doi: 10.1007/s00401-021-02327-x. pii: 10.1007/s00401-021-02327-x |
| Publikations ID | PMID: 34046693 |
| Discrimination between 34 of 36 Possible Combinations of Three C>T SNP Genotypes in the Promoter by High Resolution Melting Analysis Coupled with Pyrosequencing Using A Single Primer Set. | |
| Autoren | Zappe K, Pirker C, Miedl H, Schreiber M, Heffeter P, Pfeiler G, Hacker S, Haslik W, Spiegl-Kreinecker S, Cichna-Markl M |
| Erscheinungsdaten | International journal of molecular sciences. 2021 Nov 20. pii: ijms222212527. doi: 10.3390/ijms222212527 |
| Publikations ID | PMID: 34830407 |
| The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation. | |
| Autoren | Baier D, Schoenhacker-Alte B, Rusz M, Pirker C, Mohr T, Mendrina T, Kirchhofer D, Meier-Menches SM, Hohenwallner K, Schaier M, Rampler E, Koellensperger G, Heffeter P, Keppler B, Berger W |
| Erscheinungsdaten | Pharmaceutics. 2022 Jan 20. pii: pharmaceutics14020238. doi: 10.3390/pharmaceutics14020238 |
| Publikations ID | PMID: 35213972 |
| Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasiveness. | |
| Autoren | Gabler L, Jaunecker CN, Katz S, van Schoonhoven S, Englinger B, Pirker C, Mohr T, Vician P, Stojanovic M, Woitzuck V, Laemmerer A, Kirchhofer D, Mayr L, LaFranca M, Erhart F, Grissenberger S, Wenninger-Weinzierl A, Sturtzel C, Kiesel B, Lang A, Marian B, Grasl-Kraupp B, Distel M, Schüler J, Gojo J, Grusch M, Spiegl-Kreinecker S, Donoghue DJ, Lötsch D, Berger W |
| Erscheinungsdaten | Acta neuropathologica communications. 2022 Apr 28. doi: 10.1186/s40478-022-01363-2. pii: 10.1186/s40478-022-01363-2 |
| Publikations ID | PMID: 35484633 |
| Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma. | |
| Autoren | Sorger H, Dey S, Vieyra-Garcia PA, Pölöske D, Teufelberger AR, de Araujo ED, Sedighi A, Graf R, Spiegl B, Lazzeri I, Braun T, Garces de Los Fayos Alonso I, Schlederer M, Timelthaler G, Kodajova P, Pirker C, Surbek M, Machtinger M, Graier T, Perchthaler I, Pan Y, Fink-Puches R, Cerroni L, Ober J, Otte M, Albrecht JD, Tin G, Abdeldayem A, Manaswiyoungkul P, Olaoye OO, Metzelder ML, Orlova A, Berger W, Wobser M, Nicolay JP, André F, Nguyen VA, Neubauer HA, Fleck R, Merkel O, Herling M, Heitzer E, Gunning PT, Kenner L, Moriggl R, Wolf P |
| Erscheinungsdaten | EMBO molecular medicine. 2022 Nov 7. doi: 10.15252/emmm.202115200 |
| Publikations ID | PMID: 36341492 |
| Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with Ponatinib. | |
| Autoren | Ghanim B, Baier D, Pirker C, Müllauer L, Sinn K, Lang G, Hoetzenecker K, Berger W |
| Erscheinungsdaten | Cancers. 2022 Nov 15. doi: 10.3390/cancers14225602. pii: cancers14225602 |
| Publikations ID | PMID: 36428694 |
| Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin. | |
| Autoren | Ries A, Flehberger D, Slany A, Pirker C, Mader JC, Mohr T, Schelch K, Sinn K, Mosleh B, Hoda MA, Dome B, Dolznig H, Krupitza G, Müllauer L, Gerner C, Berger W, Grusch M |
| Erscheinungsdaten | Journal of experimental & clinical cancer research : CR. 2023 Jan 23. doi: 10.1186/s13046-022-02582-0. pii: 10.1186/s13046-022-02582-0 |
| Publikations ID | PMID: 36683050 |
| A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance. | |
| Autoren | Fronik P, Gutmann M, Vician P, Stojanovic M, Kastner A, Heffeter P, Pirker C, Keppler BK, Berger W, Kowol CR |
| Erscheinungsdaten | Communications chemistry. 2022 Apr 6. doi: 10.1038/s42004-022-00661-z. pii: 10.1038/s42004-022-00661-z. pmc: PMC9814792 |
| Publikations ID | PMID: 36697790 |
| Landomycins as glutathione-depleting agents and natural fluorescent probes for cellular Michael adduct-dependent quinone metabolism. | |
| Autoren | Terenzi A, La Franca M, van Schoonhoven S, Panchuk R, Martínez Á, Heffeter P, Gober R, Pirker C, Vician P, Kowol CR, Stoika R, Salassa L, Rohr J, Berger W |
| Erscheinungsdaten | Communications chemistry. 2021 Nov 25. doi: 10.1038/s42004-021-00600-4. pii: 10.1038/s42004-021-00600-4. pmc: PMC9814637 |
| Publikations ID | PMID: 36697631 |
| Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands. | |
| Autoren | Mendrina T, Poetsch I, Schueffl H, Baier D, Pirker C, Ries A, Keppler BK, Kowol CR, Gibson D, Grusch M, Berger W, Heffeter P |
| Erscheinungsdaten | Pharmaceutics. 2023 Feb 16. doi: 10.3390/pharmaceutics15020677. pii: pharmaceutics15020677 |
| Publikations ID | PMID: 36839999 |
| A novel EGFR inhibitor acts as potent tool for hypoxia-activated prodrug systems and exerts strong synergistic activity with VEGFR inhibition in vitro and in vivo. | |
| Autoren | Caban M, Koblmueller B, Groza D, Schueffl HH, Terenzi A, Tolios A, Mohr T, Mathuber M, Kryeziu K, Jaunecker C, Pirker C, Keppler BK, Berger W, Kowol CR, Heffeter P |
| Erscheinungsdaten | Cancer letters. 2023 May 19. doi: 10.1016/j.canlet.2023.216237. pii: S0304-3835(23)00188-X |
| Publikations ID | PMID: 37211067 |
| Aberrant DNA Methylation, Expression, and Occurrence of Transcript Variants of the ABC Transporter in Breast Cancer. | |
| Autoren | Zappe K, Kopic A, Scheichel A, Schier AK, Schmidt LE, Borutzki Y, Miedl H, Schreiber M, Mendrina T, Pirker C, Pfeiler G, Hacker S, Haslik W, Pils D, Bileck A, Gerner C, Meier-Menches S, Heffeter P, Cichna-Markl M |
| Erscheinungsdaten | Cells. 2023 May 24. doi: 10.3390/cells12111462. pii: cells12111462 |
| Publikations ID | PMID: 37296582 |
| Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells. | |
| Autoren | Ries A, Slany A, Pirker C, Mader JC, Mejri D, Mohr T, Schelch K, Flehberger D, Maach N, Hashim M, Hoda MA, Dome B, Krupitza G, Berger W, Gerner C, Holzmann K, Grusch M |
| Erscheinungsdaten | Cells. 2023 Aug 5. doi: 10.3390/cells12152006. pii: cells12152006 |
| Publikations ID | PMID: 37566084 |
| Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma. | |
| Autoren | Stockhammer P, Baumeister H, Ploenes T, Bonella F, Theegarten D, Dome B, Pirker C, Berger W, Hegedüs L, Baranyi M, Schuler M, Deshayes S, Bölükbas S, Aigner C, Blanquart C, Hegedüs B |
| Erscheinungsdaten | Lung cancer (Amsterdam, Netherlands). 2023 Sep 7. doi: 10.1016/j.lungcan.2023.107360. pii: S0169-5002(23)00898-X |
| Publikations ID | PMID: 37713954 |
| Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer in the Real-World Setting in Central Europe: The INSIGHT Study. | |
| Autoren | Ramlau R, Cufer T, Berzinec P, Dziadziuszko R, Olszewski W, Popper H, Bajcic P, Dušek L, Zbozinkova Z, Pirker R |
| Erscheinungsdaten | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2015 Aug 21. doi: 10.1097/JTO.0000000000000621. pii: 01243894-201509000-00019 |
| Publikations ID | PMID: 26291014 |
| Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. | |
| Autoren | Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF |
| Erscheinungsdaten | Lancet (London, England). 2015 May 31. pii: S0140-6736(15)60995-3. doi: 10.1016/S0140-6736(15)60995-3 |
| Publikations ID | PMID: 26040499 |
| Adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Translational lung cancer research. 2015 Mar 25. doi: 10.3978/j.issn.2218-6751.2014.09.13. pii: tlcr-03-05-305. pmc: PMC4367797 |
| Publikations ID | PMID: 25806316 |
| Epidermal growth factor receptor-directed monoclonal antibodies in nonsmall cell lung cancer: an update. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Current opinion in oncology. 2015 Feb 4. doi: 10.1097/CCO.0000000000000162 |
| Publikations ID | PMID: 25636162 |
| Perspectives of novel imaging techniques for staging, therapy response assessment, and monitoring of surveillance in lung cancer: summary of the Dresden 2013 Post WCLC-IASLC State-of-the-Art Imaging Workshop. | |
| Autoren | Henzler T, Goldstraw P, Wenz F, Pirker R, Weder W, Apfaltrer P, Meyer M, Buesing K, Crino L, Fennell D, Fink C, Grunenwald D, Manegold C, Pilz L, Schoenberg SO, Suresh S, Vansteenkiste J, Voigt W, Wängler B, Schmid-Bindert G |
| Erscheinungsdaten | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2015 Jan 23. doi: 10.1097/JTO.0000000000000412. pii: 01243894-201502000-00004 |
| Publikations ID | PMID: 25611226 |
| Relationship between EGFR expression, EGFR mutation status, and the efficacy of chemotherapy plus cetuximab in FLEX study patients with advanced non-small-cell lung cancer. | |
| Autoren | Douillard JY, Pirker R, O'Byrne KJ, Kerr KM, Störkel S, von Heydebreck A, Grote HJ, Celik I, Shepherd FA |
| Erscheinungsdaten | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2014 Apr 11. doi: 10.1097/JTO.0000000000000141 |
| Publikations ID | PMID: 24662454 |
| Mechanism of reaction of chlorite with mammalian heme peroxidases. | |
| Autoren | Jakopitsch C, Pirker KF, Flemmig J, Hofbauer S, Schlorke D, Furtmüller PG, Arnhold J, Obinger C |
| Erscheinungsdaten | Journal of inorganic biochemistry. 2014 Feb 28. pii: S0162-0134(14)00061-0. doi: 10.1016/j.jinorgbio.2014.02.010. pmc: PMC4003552 |
| Publikations ID | PMID: 24632343 |
| Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer. | |
| Autoren | Ma X, Rousseau V, Sun H, Lantuejoul S, Filipits M, Pirker R, Popper H, Mendiboure J, Vataire AL, Le Chevalier T, Soria JC, Brambilla E, Dunant A, Hainaut P |
| Erscheinungsdaten | Molecular oncology. 2014 Jan 15. pii: S1574-7891(13)00187-7. doi: 10.1016/j.molonc.2013.12.015 |
| Publikations ID | PMID: 24495481 |
| Three Metachronous Osteosarcomas within 22 Years without Pulmonary Metastases: A Case Report and Review of the Literature. | |
| Autoren | Pirker-Frühauf UM, Friesenbichler J, Rabitsch K, Liegl-Atzwanger B, Bauernhofer T, Windhager R, Leithner A |
| Erscheinungsdaten | Case reports in orthopedics. 2013 Dec 25. doi: 10.1155/2013/197287. pmc: PMC3886224 |
| Publikations ID | PMID: 24455368 |
| Overcoming resistance to first generation EGFR TKIs with cetuximab in combination with chemotherapy in an EGFR mutated advanced stage NSCLC patient. | |
| Autoren | Pircher A, Manzl C, Fiegl M, Popper H, Pirker R, Hilbe W |
| Erscheinungsdaten | Lung cancer (Amsterdam, Netherlands). 2013 Dec 25. pii: S0169-5002(13)00572-2. doi: 10.1016/j.lungcan.2013.12.007 |
| Publikations ID | PMID: 24412619 |
| Novel drugs against non-small-cell lung cancer. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Current opinion in oncology. 2014 Feb 7. doi: 10.1097/CCO.0000000000000056 |
| Publikations ID | PMID: 24406751 |
| Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer. | |
| Autoren | Pujol JL, Pirker R, Lynch TJ, Butts CA, Rosell R, Shepherd FA, Vansteenkiste J, O'Byrne KJ, de Blas B, Heighway J, von Heydebreck A, Thatcher N |
| Erscheinungsdaten | Lung cancer (Amsterdam, Netherlands). 2013 Nov 16. pii: S0169-5002(13)00517-5. doi: 10.1016/j.lungcan.2013.11.006 |
| Publikations ID | PMID: 24332319 |
| EGFR-directed monoclonal antibodies in non-small cell lung cancer. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Targeted oncology. 2013 Jan 9. doi: 10.1007/s11523-012-0244-7 |
| Publikations ID | PMID: 23300028 |
| EGFR-directed monoclonal antibodies in non-small cell lung cancer: how to predict efficacy? | |
| Autoren | Pirker R |
| Erscheinungsdaten | Translational lung cancer research. 2015 Mar 25. doi: 10.3978/j.issn.2218-6751.2012.10.09. pii: tlcr-01-04-269. pmc: PMC4367547 |
| Publikations ID | PMID: 25806192 |
| Hemoglobin decline in cancer patients receiving chemotherapy without an erythropoiesis-stimulating agent. | |
| Autoren | Pirker R, Pirolli M, Quigley J, Hulnick S, Legg J, Collins H, Vansteenkiste J |
| Erscheinungsdaten | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2012 Oct 25. doi: 10.1007/s00520-012-1617-2. pmc: PMC3584249 |
| Publikations ID | PMID: 23096072 |
| Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX study. | |
| Autoren | Pirker R, Pereira JR, Szczesna A, von Pawel J, Krzakowski M, Ramlau R, Vynnychenko I, Park K, Eberhardt WE, de Marinis F, Heeger S, Goddemeier T, O'Byrne KJ, Gatzemeier U |
| Erscheinungsdaten | Lung cancer (Amsterdam, Netherlands). 2012 Apr 11. pii: S0169-5002(12)00121-3. doi: 10.1016/j.lungcan.2012.03.010 |
| Publikations ID | PMID: 22498112 |
| Cetuximab in non-small-cell lung cancer. | |
| Autoren | Pirker R, Filipits M |
| Erscheinungsdaten | Translational lung cancer research. 2015 Mar 25. doi: 10.3978/j.issn.2218-6751.11.01. pii: tlcr-01-01-054. pmc: PMC4367590 |
| Publikations ID | PMID: 25806155 |
| Adjuvant chemotherapy of non-small cell lung cancer. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Tanaffos. 2014 Sep 5. pmc: PMC4153177 |
| Publikations ID | PMID: 25191395 |
| EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study. | |
| Autoren | Pirker R, Pereira JR, von Pawel J, Krzakowski M, Ramlau R, Park K, de Marinis F, Eberhardt WE, Paz-Ares L, Störkel S, Schumacher KM, von Heydebreck A, Celik I, O'Byrne KJ |
| Erscheinungsdaten | The Lancet. Oncology. 2011 Nov 4. pii: S1470-2045(11)70318-7. doi: 10.1016/S1470-2045(11)70318-7 |
| Publikations ID | PMID: 22056021 |
| Chemotherapy: advanced NSCLC--should we use doublets in elderly patients? | |
| Autoren | Pirker R |
| Erscheinungsdaten | Nature reviews. Clinical oncology. 2011 Sep 27. pii: nrclinonc.2011.147. doi: 10.1038/nrclinonc.2011.147 |
| Publikations ID | PMID: 21946845 |
| Third CECOG consensus on the systemic treatment of non-small-cell lung cancer. | |
| Autoren | Brodowicz T, Ciuleanu T, Crawford J, Filipits M, Fischer JR, Georgoulias V, Gridelli C, Hirsch FR, Jassem J, Kosmidis P, Krzakowski M, Manegold Ch, Pujol JL, Stahel R, Thatcher N, Vansteenkiste J, Minichsdorfer C, Zöchbauer-Müller S, Pirker R, Zielinski CC |
| Erscheinungsdaten | Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2011 Sep 22. pii: mdr381. doi: 10.1093/annonc/mdr381 |
| Publikations ID | PMID: 21940784 |
| Predictive markers in the adjuvant therapy of non-small cell lung cancer. | |
| Autoren | Filipits M, Pirker R |
| Erscheinungsdaten | Lung cancer (Amsterdam, Netherlands). 2011 Aug 31. pii: S0169-5002(11)00335-7. doi: 10.1016/j.lungcan.2011.06.005 |
| Publikations ID | PMID: 21885151 |
| Monoclonal antibodies against EGFR in non-small cell lung cancer. | |
| Autoren | Pirker R, Filipits M |
| Erscheinungsdaten | Critical reviews in oncology/hematology. 2010 Nov 24. pii: S1040-8428(10)00244-1. doi: 10.1016/j.critrevonc.2010.10.008 |
| Publikations ID | PMID: 21109448 |
| Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. | |
| Autoren | Pirker R, Herth FJ, Kerr KM, Filipits M, Taron M, Gandara D, Hirsch FR, Grunenwald D, Popper H, Smit E, Dietel M, Marchetti A, Manegold C, Schirmacher P, Thomas M, Rosell R, Cappuzzo F, Stahel R |
| Erscheinungsdaten | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2010 Sep 27. doi: 10.1097/JTO.0b013e3181f1c8de. pii: 01243894-201010000-00033 |
| Publikations ID | PMID: 20871269 |
| Therapy of small cell lung cancer with emphasis on oral topotecan. | |
| Autoren | Pirker R, Berzinec P, Brincat S, Kasan P, Ostoros G, Pesek M, Plāte S, Purkalne G, Rooneem R, Skricková J, Stanculeanu D, Timcheva C, Tzekova V, Zakotnik B, Zielinski CC, Zwitter M |
| Erscheinungsdaten | Lung cancer (Amsterdam, Netherlands). 2010 Jun 23. pii: S0169-5002(10)00266-7. doi: 10.1016/j.lungcan.2010.05.020 |
| Publikations ID | PMID: 20576312 |
| Chemotherapy of advanced non-small cell lung cancer. | |
| Autoren | Pirker R, Minar W |
| Erscheinungsdaten | Frontiers of radiation therapy and oncology. 2009 Nov 24. pii: 000262471. doi: 10.1159/000262471 |
| Publikations ID | PMID: 19955802 |
| Erythropoiesis-stimulating agents in patients with cancer: update on safety issues. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Expert opinion on drug safety. 2009 Aug 25. doi: 10.1517/14740330903158929 |
| Publikations ID | PMID: 19637988 |
| Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial. | |
| Autoren | Pirker R, Pereira JR, Szczesna A, von Pawel J, Krzakowski M, Ramlau R, Vynnychenko I, Park K, Yu CT, Ganul V, Roh JK, Bajetta E, O'Byrne K, de Marinis F, Eberhardt W, Goddemeier T, Emig M, Gatzemeier U |
| Erscheinungsdaten | Lancet (London, England). 2009 May 4. pii: S0140-6736(09)60569-9. doi: 10.1016/S0140-6736(09)60569-9 |
| Publikations ID | PMID: 19410716 |
| Targeted therapies in lung cancer. | |
| Autoren | Pirker R, Filipits M |
| Erscheinungsdaten | Current pharmaceutical design. 2009 Jan 19. |
| Publikations ID | PMID: 19149612 |
| Cetuximab: potential role as first-line treatment for advanced non-small cell lung cancer. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Clinical advances in hematology & oncology : H&O. 2008 Nov 10. |
| Publikations ID | PMID: 18997663 |
| Safety and efficacy of darbepoetin alpha in previously untreated extensive-stage small-cell lung cancer treated with platinum plus etoposide. | |
| Autoren | Pirker R, Ramlau RA, Schuette W, Zatloukal P, Ferreira I, Lillie T, Vansteenkiste JF |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 May 9. pii: 26/14/2342. doi: 10.1200/JCO.2007.15.0748 |
| Publikations ID | PMID: 18467726 |
| Integrating epidermal growth factor receptor-targeted therapies into platinum-based chemotherapy regimens for newly diagnosed non-small-cell lung cancer. | |
| Autoren | Pirker R, Minar W, Filipits M |
| Erscheinungsdaten | Clinical lung cancer. 2009 May 7. pii: 8283T3NM41K23842. doi: 10.3816/CLC.2008.s.016 |
| Publikations ID | PMID: 19419924 |
| Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma. | |
| Autoren | Herberger B, Puhalla H, Lehnert M, Wrba F, Novak S, Brandstetter A, Gruenberger B, Gruenberger T, Pirker R, Filipits M |
| Erscheinungsdaten | Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Aug 16. pii: 13/16/4795. doi: 10.1158/1078-0432.CCR-07-0738 |
| Publikations ID | PMID: 17699857 |
| Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program. | |
| Autoren | Filipits M, Haddad V, Schmid K, Huynh A, Dunant A, André F, Brambilla E, Stahel R, Pignon JP, Soria JC, Popper HH, Le Chevalier T, Pirker R |
| Erscheinungsdaten | Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Jul 3. pii: 13/13/3892. doi: 10.1158/1078-0432.CCR-06-2446 |
| Publikations ID | PMID: 17606722 |
| Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program. | |
| Autoren | Filipits M, Pirker R, Dunant A, Lantuejoul S, Schmid K, Huynh A, Haddad V, André F, Stahel R, Pignon JP, Soria JC, Popper HH, Le Chevalier T, Brambilla E |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Jul 2. pii: 25/19/2735. doi: 10.1200/JCO.2006.08.2867 |
| Publikations ID | PMID: 17602078 |
| Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer. | |
| Autoren | Heller G, Geradts J, Ziegler B, Newsham I, Filipits M, Markis-Ritzinger EM, Kandioler D, Berger W, Stiglbauer W, Depisch D, Pirker R, Zielinski CC, Zöchbauer-Müller S |
| Erscheinungsdaten | Breast cancer research and treatment. 2007 Jan 27. doi: 10.1007/s10549-006-9377-7 |
| Publikations ID | PMID: 17260099 |
| Achieving full-dose, on-schedule administration of ACE chemotherapy every 14 days for the treatment of patients with extensive small-cell lung cancer. | |
| Autoren | Pirker R, Ulsperger E, Messner J, Aigner K, Forstner B, Bacon P, Easton V, Skacel T |
| Erscheinungsdaten | Lung. 2007 Jan 19. doi: 10.1007/s00408-005-2594-8 |
| Publikations ID | PMID: 17235728 |
| Safety considerations for erythropoietin treatment in patients with cancer. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Expert opinion on drug safety. 2006 Dec 21. doi: 10.1517/14740338.6.1.63 |
| Publikations ID | PMID: 17181453 |
| Once-weekly epoetin beta (30,000 IU) in anemic patients with lung cancer receiving chemotherapy. | |
| Autoren | Pirker R, Lehnert M, Minar W |
| Erscheinungsdaten | Lung cancer (Amsterdam, Netherlands). 2006 Nov 3. pii: S0169-5002(06)00529-0. doi: 10.1016/j.lungcan.2006.09.020 |
| Publikations ID | PMID: 17084484 |
| Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer. | |
| Autoren | Pohl G, Krajnik G, Malayeri R, Müller RM, Klepetko W, Eckersberger F, Schäfer-Prokop C, Pokrajac B, Schmeikal S, Maier A, Ambrosch G, Woltsche M, Minar W, Pirker R |
| Erscheinungsdaten | Lung cancer (Amsterdam, Netherlands). 2006 Aug 22. pii: S0169-5002(06)00313-8. doi: 10.1016/j.lungcan.2006.05.027 |
| Publikations ID | PMID: 16926060 |
| Application and safety of erythropoietin in cancer management. | |
| Autoren | Pirker R, Minar W |
| Erscheinungsdaten | Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2005 Jun 16. pii: 16/suppl_2/ii47. doi: 10.1093/annonc/mdi716 |
| Publikations ID | PMID: 15958474 |
| Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group. | |
| Autoren | Filipits M, Pohl G, Rudas M, Dietze O, Lax S, Grill R, Pirker R, Zielinski CC, Hausmaninger H, Kubista E, Samonigg H, Jakesz R |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Feb 18. pii: 23/6/1161. doi: 10.1200/JCO.2005.03.033 |
| Publikations ID | PMID: 15718312 |
| Therapy of advanced non-small-cell lung cancer (take home message). | |
| Autoren | Pirker R |
| Erscheinungsdaten | Lung cancer (Amsterdam, Netherlands). 2004 Nov 19. pii: S0169-5002(04)80034-5. doi: 10.1016/j.lungcan.2004.07.966 |
| Publikations ID | PMID: 15552808 |
| Darbepoetin alfa for the treatment of cancer-related anemia: an update. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Expert review of anticancer therapy. 2004 Oct 15. pii: ERA040505. doi: 10.1586/14737140.4.5.735 |
| Publikations ID | PMID: 15485310 |
| Two- versus three-drug combinations in the chemotherapy of advanced non-small-cell lung cancer. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Lung cancer (Amsterdam, Netherlands). 2002 Dec 6. pii: S0169500202002702 |
| Publikations ID | PMID: 12468147 |
| New drugs in the palliative chemotherapy of advanced non-small-cell lung cancer. | |
| Autoren | Malayeri R, Pirker R, Huber H |
| Erscheinungsdaten | Onkologie. 2001 Nov 5. pii: 55121. doi: 55121 |
| Publikations ID | PMID: 11694767 |
| P-glycoprotein and MRP1 expression in axillary lymph node metastases of breast cancer patients. | |
| Autoren | Zöchbauer-Müller S, Filipits M, Rudas M, Brunner R, Krajnik G, Suchomel R, Schmid K, Pirker R |
| Erscheinungsdaten | Anticancer research. 2001 Apr 12. |
| Publikations ID | PMID: 11299725 |
| Drug resistance factors in acute myeloid leukemia: a comparative analysis. | |
| Autoren | Filipits M, Stranzl T, Pohl G, Heinzl H, Jäger U, Geissler K, Fonatsch C, Haas OA, Lechner K, Pirker R |
| Erscheinungsdaten | Leukemia. 2000 Feb 2. |
| Publikations ID | PMID: 10637479 |
| MRP expression in acute myeloid leukemia. An update. | |
| Autoren | Filipits M, Stranzl T, Pohl G, Suchomel RW, Zöchbauer S, Brunner R, Lechner K, Pirker R |
| Erscheinungsdaten | Advances in experimental medicine and biology. 1999 Nov 4. |
| Publikations ID | PMID: 10500789 |
| The lung resistance protein (LRP) predicts poor outcome in acute myeloid leukemia. | |
| Autoren | Pirker R, Pohl G, Stranzl T, Suchomel RW, Scheper RJ, Jäger U, Geissler K, Lechner K, Filipits M |
| Erscheinungsdaten | Advances in experimental medicine and biology. 1999 Nov 4. |
| Publikations ID | PMID: 10500788 |
| The TP53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non-small cell lung cancer. | |
| Autoren | Kandioler-Eckersberger D, Kappel S, Mittlböck M, Dekan G, Ludwig C, Janschek E, Pirker R, Wolner E, Eckersberger F |
| Erscheinungsdaten | The Journal of thoracic and cardiovascular surgery. 1999 Apr 16. pii: S002252239900149X |
| Publikations ID | PMID: 10096970 |
| Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trial. | |
| Autoren | Krajnik G, Wein W, Greil R, Marhold F, Mohn-Staudner A, Kummer F, Malayeri R, Zöchbauer-Müller S, Huber H, Pirker R |
| Erscheinungsdaten | European journal of cancer (Oxford, England : 1990). 1999 Feb 25. pii: S0959-8049(98)00235-4 |
| Publikations ID | PMID: 10023326 |
| Expression of the lung resistance protein predicts poor outcome in de novo acute myeloid leukemia. | |
| Autoren | Filipits M, Pohl G, Stranzl T, Suchomel RW, Scheper RJ, Jäger U, Geissler K, Lechner K, Pirker R |
| Erscheinungsdaten | Blood. 1998 Mar 16. |
| Publikations ID | PMID: 9473213 |
| Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome. | |
| Autoren | Filipits M, Suchomel RW, Zöchbauer S, Brunner R, Lechner K, Pirker R |
| Erscheinungsdaten | Clinical cancer research : an official journal of the American Association for Cancer Research. 1999 Feb 25. |
| Publikations ID | PMID: 9815827 |
| MDR1 RNA transcripts do not indicate long-term prognosis in colorectal carcinomas. | |
| Autoren | Zöchbauer S, Wallner J, Haider K, Depisch D, Huber H, Pirker R |
| Erscheinungsdaten | European journal of cancer (Oxford, England : 1990). 1997 Nov 3. pii: S0959804997001391 |
| Publikations ID | PMID: 9337699 |
| Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy. | |
| Autoren | Berger T, Malayeri R, Doppelbauer A, Krajnik G, Huber H, Auff E, Pirker R |
| Erscheinungsdaten | European journal of cancer (Oxford, England : 1990). 1997 Nov 3. pii: S0959804997001032 |
| Publikations ID | PMID: 9337680 |
| Immunocytochemical detection of the multidrug resistance-associated protein and P-glycoprotein in acute myeloid leukemia: impact of antibodies, sample source and disease status. | |
| Autoren | Filipits M, Suchomel RW, Lechner K, Pirker R |
| Erscheinungsdaten | Leukemia. 1997 Jul 17. |
| Publikations ID | PMID: 9204994 |
| Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas. | |
| Autoren | Fillpits M, Suchomel RW, Dekan G, Stiglbauer W, Haider K, Depisch D, Pirker R |
| Erscheinungsdaten | British journal of cancer. 1997 Feb 20. pmc: PMC2063277 |
| Publikations ID | PMID: 9010028 |
| Multidrug resistance in leukemias and its reversal. | |
| Autoren | Malayeri R, Filipits M, Suchomel RW, Zöchbauer S, Lechner K, Pirker R |
| Erscheinungsdaten | Leukemia & lymphoma. 1997 Apr 11. doi: 10.3109/10428199609054853 |
| Publikations ID | PMID: 9031075 |
| MRP and MDR1 gene expression in primary breast carcinomas. | |
| Autoren | Filipits M, Suchomel RW, Dekan G, Haider K, Valdimarsson G, Depisch D, Pirker R |
| Erscheinungsdaten | Clinical cancer research : an official journal of the American Association for Cancer Research. 1999 Feb 9. |
| Publikations ID | PMID: 9816292 |
| Clinical relevance of drug resistance genes in malignant disease. | |
| Autoren | Filipits M, Suchomel RW, Zöchbauer S, Malayeri R, Pirker R |
| Erscheinungsdaten | Leukemia. 1996 Jul 26. |
| Publikations ID | PMID: 8656694 |
| Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC). | |
| Autoren | Pirker R, Krajnik G, Zöchbauer S, Malayeri R, Kneussl M, Huber H |
| Erscheinungsdaten | Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 1996 Mar 27. |
| Publikations ID | PMID: 8589023 |
| P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia. | |
| Autoren | Zöchbauer S, Gsur A, Brunner R, Kyrle PA, Lechner K, Pirker R |
| Erscheinungsdaten | Leukemia. 1994 Jul 13. |
| Publikations ID | PMID: 7516030 |
| MDR1 gene expression in chronic lymphocytic leukemia. | |
| Autoren | Wallner J, Gisslinger H, Gisslinger B, Gsur A, Götzl M, Zöchbauer S, Pirker R |
| Erscheinungsdaten | Leukemia & lymphoma. 1994 Sep 2. doi: 10.3109/10428199409056298 |
| Publikations ID | PMID: 7914128 |
| MDR1 gene expression in primary colorectal carcinomas. | |
| Autoren | Pirker R, Wallner J, Gsur A, Götzl M, Zöchbauer S, Scheithauer W, Depisch D |
| Erscheinungsdaten | British journal of cancer. 1993 Nov 15. pmc: PMC1968613 |
| Publikations ID | PMID: 8398695 |
| Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C. | |
| Autoren | Scheithauer W, Kornek G, Haider K, Kwasny W, Schenk T, Pirker R, Depisch D |
| Erscheinungsdaten | Breast cancer research and treatment. 1993 Nov 16. |
| Publikations ID | PMID: 8400323 |
| MDR1 gene expression and treatment outcome in acute myeloid leukemia. | |
| Autoren | Pirker R, Wallner J, Geissler K, Linkesch W, Haas OA, Bettelheim P, Hopfner M, Scherrer R, Valent P, Havelec L |
| Erscheinungsdaten | Journal of the National Cancer Institute. 1991 Jun 6. |
| Publikations ID | PMID: 2023272 |
| Expression of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia. | |
| Autoren | Pirker R, Goldstein LJ, Ludwig H, Linkesch W, Lechner C, Gottesman MM, Pastan I |
| Erscheinungsdaten | Cancer communications. 1990 Aug 23. |
| Publikations ID | PMID: 2639725 |
| Immunotoxins against solid tumors. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Journal of cancer research and clinical oncology. 1988 Oct 11. |
| Publikations ID | PMID: 3045130 |
| Third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Current opinion in oncology. 2015 Dec 30. doi: 10.1097/CCO.0000000000000260 |
| Publikations ID | PMID: 26720671 |
| Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality. | |
| Autoren | Pavo N, Raderer M, Hülsmann M, Neuhold S, Adlbrecht C, Strunk G, Goliasch G, Gisslinger H, Steger GG, Hejna M, Köstler W, Zöchbauer-Müller S, Marosi C, Kornek G, Auerbach L, Schneider S, Parschalk B, Scheithauer W, Pirker R, Drach J, Zielinski C, Pacher R |
| Erscheinungsdaten | Heart (British Cardiac Society). 2015 Sep 28. pii: heartjnl-2015-307848. doi: 10.1136/heartjnl-2015-307848 |
| Publikations ID | PMID: 26416836 |
| Alectinib in RET-rearranged non-small cell lung cancer-Another progress in precision medicine? | |
| Autoren | Pirker R, Filipits M |
| Erscheinungsdaten | Translational lung cancer research. 2016 Jan 22. doi: 10.3978/j.issn.2218-6751.2015.03.08. pii: tlcr-04-06-797 |
| Publikations ID | PMID: 26798590 |
| Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer. | |
| Autoren | Brambilla E, Le Teuff G, Marguet S, Lantuejoul S, Dunant A, Graziano S, Pirker R, Douillard JY, Le Chevalier T, Filipits M, Rosell R, Kratzke R, Popper H, Soria JC, Shepherd FA, Seymour L, Tsao MS |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Feb 1. pii: JCO.2015.63.0970. doi: 10.1200/JCO.2015.63.0970 |
| Publikations ID | PMID: 26834066 |
| Prognostic and predictive effect of TP53 mutations in non-small cell lung cancer patients from adjuvant cisplatin-based therapy randomized trials: a LACE-bio pooled analysis. | |
| Autoren | Ma X, Le Teuff G, Lacas B, Tsao MS, Graziano S, Pignon JP, Douillard JY, Le Chevalier T, Seymour L, Filipits M, Pirker R, Janne P, Shepherd FA, Brambilla E, Soria JC, Hainaut P |
| Erscheinungsdaten | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016 Feb 16. pii: S1556-0864(16)00359-2. doi: 10.1016/j.jtho.2016.02.002 |
| Publikations ID | PMID: 26899019 |
| Personalized treatment of advanced non-small-cell lung cancer in routine clinical practice. | |
| Autoren | Pirker R, Filipits M |
| Erscheinungsdaten | Cancer metastasis reviews. 2016 Mar 12. doi: 10.1007/s10555-016-9612-6. pii: 10.1007/s10555-016-9612-6 |
| Publikations ID | PMID: 26970967 |
| Scientific Advances in Lung Cancer 2015. | |
| Autoren | Tsao AS, Scagliotti GV, Bunn PA, Carbone DP, Warren GW, Bai C, de Koning HJ, Yousaf-Khan AU, McWilliams A, Tsao MS, Adusumilli PS, Rami-Porta R, Asamura H, Van Schil PE, Darling GE, Ramalingam SS, Gomez DR, Rosenzweig KE, Zimmermann S, Peters S, Ignatius Ou SH, Reungwetwattana T, Jänne PA, Mok TS, Wakelee HA, Pirker R, Mazières J, Brahmer JR, Zhou Y, Herbst RS, Papadimitrakopoulou VA, Redman MW, Wynes MW, Gandara DR, Kelly RJ, Hirsch FR, Pass HI |
| Erscheinungsdaten | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016 Mar 21. pii: S1556-0864(16)30022-3. doi: 10.1016/j.jtho.2016.03.012 |
| Publikations ID | PMID: 27013409 |
| Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement. | |
| Autoren | Vrdoljak E, Bodoky G, Jassem J, Popescu RA, Mardiak J, Pirker R, Čufer T, Bešlija S, Eniu A, Todorović V, Kubáčková K, Kurteva G, Tomašević Z, Sallaku A, Smichkoska S, Bajić Ž, Šikić BI |
| Erscheinungsdaten | The oncologist. 2016 Jul 8. pii: theoncologist.2016-0137. doi: 10.1634/theoncologist.2016-0137 |
| Publikations ID | PMID: 27401890 |
| Improving survival of patients with locally advanced non-small-cell cancer remains a challenge: comment to PROCLAIM. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Journal of thoracic disease. 2016 Aug 9. doi: 10.21037/jtd.2016.05.54. pii: jtd-08-07-E607 |
| Publikations ID | PMID: 27501237 |
| IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells. | |
| Autoren | Bauer K, Hadzijusufovic E, Cerny-Reiterer S, Hoermann G, Reifinger M, Pirker A, Valent P, Willmann M |
| Erscheinungsdaten | Veterinary and comparative oncology. 2016 Aug 9. doi: 10.1111/vco.12260 |
| Publikations ID | PMID: 27507155 |
| From diagnosis to therapy in lung cancer: management of CT detected pulmonary nodules, a summary of the 2015 Chinese-German Lung Cancer Expert Panel. | |
| Autoren | Su C, Meyer M, Pirker R, Voigt W, Shi J, Pilz L, Huber RM, Wu Y, Wang J, He Y, Wang X, Zhang J, Zhi X, Shi M, Zhu B, Schoenberg SS, Henzler T, Manegold C, Zhou C, Roessner ED |
| Erscheinungsdaten | Translational lung cancer research. 2016 Sep 21. doi: 10.21037/tlcr.2016.07.09. pii: tlcr-05-04-377 |
| Publikations ID | PMID: 27652202 |
| Palliative care units in lung cancer in the real-world setting: a single institution's experience and its implications. | |
| Autoren | Masel EK, Schur S, Nemecek R, Mayrhofer M, Huber P, Adamidis F, Maehr B, Unseld M, Watzke HH, Pirker R |
| Erscheinungsdaten | Annals of palliative medicine. pii: apm.2016.08.06. doi: 10.21037/apm.2016.08.06 |
| Publikations ID | PMID: 27701880 |
| The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna. | |
| Autoren | Kiesewetter B, Raderer M, Steger GG, Bartsch R, Pirker R, Zöchbauer-Müller S, Prager G, Krainer M, Preusser M, Schmidinger M, Zielinski CC |
| Erscheinungsdaten | ESMO open. doi: 10.1136/esmoopen-2016-000066. pii: esmoopen-2016-000066 |
| Publikations ID | PMID: 27843624 |
| An international, randomized, placebo-controlled, double-blind phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non-small cell lung cancer (NSCLC). | |
| Autoren | Scagliotti G, Vynnychenko I, Ichinose Y, Park K, Kubota K, Blackhall FH, Pirker R, Galiulin R, Ciuleanu T, Sydorenko O, Dediu M, Papai-Szekely Z, Martinez Banaclocha N, McCoy S, Yao B, Hei YJ, Spigel DR |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.18_suppl.lba7512 |
| Publikations ID | PMID: 27937148 |
| MSH2 and adjuvant cisplatin-based chemotherapy in non-small cell lung cancer. | |
| Autoren | Fouret P, Planchard D, Mendiboure J, Kamal NS, Olaussen KA, Bertrand P, Pirker R, Dunant A, Le Chevalier T, Soria JC |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Jan 1. pii: 10.1200/jco.2009.27.18_suppl.cra7502 |
| Publikations ID | PMID: 27937603 |
| Efficacy of erlotinib in patients (pts) with advanced non-small-cell lung cancer (NSCLC) relative to clinical characteristics: Subset analyses from the TRUST study. | |
| Autoren | Allan SG, Bosquee L, Franke A, Pirker R, Scagliotti GV |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 1. pii: 10.1200/jco.2008.26.15_suppl.8081 |
| Publikations ID | PMID: 27948957 |
| FLEX: A randomized, multicenter, phase III study of cetuximab in combination with cisplatin/vinorelbine (CV) versus CV alone in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC). | |
| Autoren | Pirker R, Szczesna A, von Pawel J, Krzakowski M, Ramlau R, Park K, Gatzemeier U, Bajeta E, Emig M, Pereira JR |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 1. pii: 10.1200/jco.2008.26.15_suppl.3 |
| Publikations ID | PMID: 27948496 |
| Prognostic value of class III b-tubulin (TUBB3) in operable non-small cell lung cancer (NSCLC) and predictive value for adjuvant cisplatin-based chemotherapy (CT): A validation study on three randomized trials. | |
| Autoren | Reiman T, Seve P, Vataire A, Dunant A, Rosell R, Graziano S, Seymour L, Pirker R, Lai R |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 1. pii: 10.1200/jco.2008.26.15_suppl.7506 |
| Publikations ID | PMID: 27947282 |
| Initial safety results of an expanded access program (EAP) of erlotinib in non-small cell lung cancer (NSCLC). | |
| Autoren | Reck M, Perng R, Groen H, Riska H, Pirker R, Sederholm C, Caspar C, Boyer M, Berzinec P, Allan S |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Jan 1. pii: 10.1200/jco.2006.24.18_suppl.7190 |
| Publikations ID | PMID: 27953728 |
| Cell cycle regulators and benefit of adjuvant chemotherapy in patients with non-small cell lung cancer. | |
| Autoren | Pirker R, Filipits M, Dunant A, Lantuejoul S, Schmid K, Huynh A, Soria J, Popper HH, Le Chevalier T, Brambilla E |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Jan 1. pii: 10.1200/jco.2006.24.18_suppl.7100 |
| Publikations ID | PMID: 27953613 |
| Phase III study comparing cisplatin/vinorelbine plus cetuximab versus cisplatin/vinorelbine as first-line treatment for patients with epidermal growth factor (EGFR)-expressing advanced non-small cell lung cancer (NSCLC) (FLEX). | |
| Autoren | Von Pawel J, Park K, Pereira JR, Szczesna A, Yu C, Ganul VL, Krzakowski M, Roh JK, Pilz K, Pirker R |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Jan 1. pii: 10.1200/jco.2006.24.18_suppl.7109 |
| Publikations ID | PMID: 27953547 |
| MSH2 and adjuvant cisplatin-based chemotherapy in non-small cell lung cancer. | |
| Autoren | Fouret P, Planchard D, Mendiboure J, Kamal NS, Olaussen KA, Bertrand P, Pirker R, Dunant A, Le Chevalier T, Soria JC |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 May 27. pii: 10.1200/jco.2009.27.15_suppl.cra7502 |
| Publikations ID | PMID: 27963172 |
| Molecular and clinical predictors of outcome for cetuximab in non-small cell lung cancer (NSCLC): Data from the FLEX study. | |
| Autoren | O'Byrne KJ, Bondarenko I, Barrios C, Eschbach C, Martens U, Hotko Y, Kortsik C, Celik I, Stroh C, Pirker R |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Jan 1. pii: 10.1200/jco.2009.27.15_suppl.8007 |
| Publikations ID | PMID: 27962785 |
| Prognostic factors in advanced NSCLC: Experience from the FLEX trial. | |
| Autoren | Pirker R, Rodrigues-Pereira J, Szczesna A, Von Pawel J, Krzakowski M, Ramlau R, Vynnychenko I, Park K, Emig M, Gatzemeier U |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Jan 1. pii: 10.1200/jco.2009.27.15_suppl.8083 |
| Publikations ID | PMID: 27962658 |
| Use of immunohistochemical evaluation of DNA repair proteins to demonstrate cisplatin response prediction in resected NSCLC squamous cell carcinoma. | |
| Autoren | Pierceall WE, Sprott KM, Brambilla E, Pirker R, Popper HH, Wang X, Chen Y, Quan S, Filipits M, Alaparthi L, Kutok J, Weaver DT, Al-Adhami M, Andre F, Le Chevalier T, Ward BE, Soria J |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.10579 |
| Publikations ID | PMID: 28021978 |
| Rate of hemoglobin (Hb) decline from less than 10 g/dl to less than 9 g/dl in placebo-treated patients (pts) receiving chemotherapy: A pooled analysis of data from six randomized darbepoetin alfa trials. | |
| Autoren | Pirker R, Collins H, Legg JC, Vansteenkiste JF |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.e19637 |
| Publikations ID | PMID: 28021779 |
| An international, randomized, placebo-controlled, double-blind phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non-small cell lung cancer (NSCLC). | |
| Autoren | Scagliotti G, Vynnychenko I, Ichinose Y, Park K, Kubota K, Blackhall FH, Pirker R, Galiulin R, Ciuleanu T, Sydorenko O, Dediu M, Papai-Szekely Z, Martinez Banaclocha N, McCoy S, Yao B, Hei YJ, Spigel DR |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.lba7512 |
| Publikations ID | PMID: 28020760 |
| A phase II study of pegfilgrastim to support ACE 14 chemotherapy for the treatment of subjects with small cell lung cancer (SCLC; extensive disease). | |
| Autoren | Pirker R, Ulsperger E, Aigner K, Messner J |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Jan 1. pii: 10.1200/jco.2004.22.14_suppl.7216 |
| Publikations ID | PMID: 28013814 |
| PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer. | |
| Autoren | Tsao MS, Le Teuff G, Shepherd FA, Landais C, Hainaut P, Filipits M, Pirker R, Le Chevalier T, Graziano S, Kratze R, Soria JC, Pignon JP, Seymour L, Brambilla E |
| Erscheinungsdaten | Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Jan 30. pii: mdx003. doi: 10.1093/annonc/mdx003 |
| Publikations ID | PMID: 28137741 |
| 1499PEFFECTIVENESS OF DARBEPOETIN ALFA (DA) FOR CHEMOTHERAPY-INDUCED ANAEMIA (CIA) WHEN INITIATED AT HAEMOGLOBIN (HB) ≤10 G/DL. | |
| Autoren | Pirker R, Vansteenkiste JF, Hedenus M, Hernandez E, Belton L, Terwey J |
| Erscheinungsdaten | Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2242185. doi: 10.1093/annonc/mdu356.20 |
| Publikations ID | PMID: 28172008 |
| 167OPROGNOSTIC AND PREDICTIVE BIOMARKERS FOR ACT (ADJUVANT CHEMOTHERAPY) IN RESECTED NON-SMALL CELL LUNG CANCER (R-NSCLC): LACE-BIO. | |
| Autoren | Seymour LK, Le Teuff G, Tsao M, Brambilla E, Shepherd F, Soria J, Kratzke R, Graziano S, Douillard J, Rosell R, Reiman A, Lacas B, Bourredjem A, Le Chevalier T, Pirker R, Filipits M, Hainaut P, Janne PA, Pignon J |
| Erscheinungsdaten | Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2238214. doi: 10.1093/annonc/mdu326.1 |
| Publikations ID | PMID: 28170565 |
| Milestones in the systemic treatment of lung cancer. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Memo. 2017 Feb 6. doi: 10.1007/s12254-017-0313-9. pii: 313. pmc: PMC5357246 |
| Publikations ID | PMID: 28367252 |
| Molecular Biomarkers in Advanced Non-Small-Cell Lung Cancer: A Rapidly Changing Field. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Journal of oncology practice. 2017 Apr 11. doi: 10.1200/JOP.2017.022780 |
| Publikations ID | PMID: 28399383 |
| Subclinical involvement of the liver is associated with prognosis in treatment naïve cancer patients. | |
| Autoren | Pavo N, Raderer M, Goliasch G, Wurm R, Strunk G, Cho A, Novak JF, Gisslinger H, Steger GG, Hejna M, Köstler W, Zöchbauer-Müller S, Marosi C, Kornek G, Auerbach L, Schneider ST, Parschalk B, Scheithauer W, Pirker R, Kiesewetter B, Pacher R, Zielinski C, Hülsmann M |
| Erscheinungsdaten | Oncotarget. 2017 Apr 16. pii: 17131. doi: 10.18632/oncotarget.17131 |
| Publikations ID | PMID: 28465470 |
| Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy. | |
| Autoren | Shepherd FA, Lacas B, Le Teuff G, Hainaut P, Jänne PA, Pignon JP, Le Chevalier T, Seymour L, Douillard JY, Graziano S, Brambilla E, Pirker R, Filipits M, Kratzke R, Soria JC, Tsao MS |
| Erscheinungsdaten | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Apr 28. doi: 10.1200/JCO.2016.71.2893 |
| Publikations ID | PMID: 28453411 |
| Trimodality therapy for Pancoast tumors: T4 is not a contraindication to radical surgery. | |
| Autoren | Waseda R, Klikovits T, Hoda MA, Hoetzenecker K, Bertoglio P, Dieckmann K, Zöchbauer-Müller S, Pirker R, Prosch H, Döme B, Klepetko W |
| Erscheinungsdaten | Journal of surgical oncology. 2017 Apr 13. doi: 10.1002/jso.24629 |
| Publikations ID | PMID: 28407246 |
| Subclinical involvement of the liver is associated with prognosis in treatment naïve cancer patients. | |
| Autoren | Pavo N, Raderer M, Goliasch G, Wurm R, Strunk G, Cho A, Novak JF, Gisslinger H, Steger GG, Hejna M, Köstler W, Zöchbauer-Müller S, Marosi C, Kornek G, Auerbach L, Schneider ST, Parschalk B, Scheithauer W, Pirker R, Kiesewetter B, Pacher R, Zielinski C, Hülsmann M |
| Erscheinungsdaten | Oncotarget. 2017 Apr 16. doi: 10.18632/oncotarget.17131. pii: 17131. pmc: PMC5655279 |
| Publikations ID | PMID: 29113384 |
| EGFR monoclonal antibody biomarkers in advanced NSCLC: from translational research to clinical implementation. | |
| Autoren | Pirker R |
| Erscheinungsdaten | The Lancet. Oncology. 2017 Nov 20. pii: S1470-2045(17)30873-2. doi: 10.1016/S1470-2045(17)30873-2 |
| Publikations ID | PMID: 29169876 |
| EGFR tyrosine kinase inhibitors as first-line therapy in advanced EGFR mutation-positive non-small cell lung cancer: strategies to improve clinical outcome. | |
| Autoren | Tiefenbacher A, Pirker R |
| Erscheinungsdaten | Journal of thoracic disease. doi: 10.21037/jtd.2017.10.02. pii: jtd-09-11-4208. pmc: PMC5720983 |
| Publikations ID | PMID: 29268473 |
| Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy. | |
| Autoren | Manegold C, Adjei A, Bussolino F, Cappuzzo F, Crino L, Dziadziuszko R, Ettinger D, Fennell D, Kerr K, Le Chevalier T, Leighl N, Papotti M, Paz-Ares L, Pérol M, Peters S, Pirker R, Quoix E, Reck M, Smit E, Vokes E, van Zandwijk N, Zhou C |
| Erscheinungsdaten | ESMO open. 2017 Jan 13. doi: 10.1136/esmoopen-2016-000118. pii: esmoopen-2016-000118. pmc: PMC5729303 |
| Publikations ID | PMID: 29435365 |
| Cell-free plasma DNA-guided treatment with osimertinib in patients with advanced EGFR-mutated NSCLC. | |
| Autoren | Buder A, Hochmair MJ, Schwab S, Bundalo T, Schenk P, Errhalt P, Mikes RE, Absenger G, Patocka K, Baumgartner B, Setinek U, Burghuber OC, Prosch H, Pirker R, Filipits M |
| Erscheinungsdaten | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2018 Mar 2. pii: S1556-0864(18)30167-9. doi: 10.1016/j.jtho.2018.02.014 |
| Publikations ID | PMID: 29505901 |
| Automatic ictal onset source localization in presurgical epilepsy evaluation. | |
| Autoren | Koren J, Gritsch G, Pirker S, Herta J, Perko H, Kluge T, Baumgartner C |
| Erscheinungsdaten | Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. 2018 Apr 6. pii: S1388-2457(18)30276-1. doi: 10.1016/j.clinph.2018.03.020 |
| Publikations ID | PMID: 29680731 |
| Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer. | |
| Autoren | Grilz E, Königsbrügge O, Posch F, Schmidinger M, Pirker R, Lang IM, Pabinger I, Ay C |
| Erscheinungsdaten | Haematologica. 2018 May 24. pii: haematol.2018.192419. doi: 10.3324/haematol.2018.192419 |
| Publikations ID | PMID: 29794142 |
| IASLC Statement Paper: Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC). | |
| Autoren | Rolfo C, Mack PC, Scagliotti GV, Baas P, Barlesi F, Bivona TG, Herbst RS, Mok TS, Peled N, Pirker R, Raez LE, Reck M, Riess JW, Sequist LV, Shepherd FA, Sholl LM, Tan DS, Wakelee HA, Wistuba II, Wynes MW, Carbone DP, Hirsch FR, Gandara DR |
| Erscheinungsdaten | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2018 Jun 6. pii: S1556-0864(18)30680-4. doi: 10.1016/j.jtho.2018.05.030 |
| Publikations ID | PMID: 29885479 |
| Automated Long-Term EEG Review: Fast and Precise Analysis in Critical Care Patients. | |
| Autoren | Koren JP, Herta J, Fürbass F, Pirker S, Reiner-Deitemyer V, Riederer F, Flechsenhar J, Hartmann M, Kluge T, Baumgartner C |
| Erscheinungsdaten | Frontiers in neurology. 2018 Jun 19. doi: 10.3389/fneur.2018.00454. pmc: PMC6020775 |
| Publikations ID | PMID: 29973906 |
| Systemic treatment of advanced non-small cell lung cancer: controversies and perspectives. | |
| Autoren | Tiefenbacher A, Pirker R |
| Erscheinungsdaten | Memo. 2018 May 18. doi: 10.1007/s12254-018-0408-y. pii: 408. pmc: PMC6006273 |
| Publikations ID | PMID: 29983826 |
| Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial. | |
| Autoren | Han B, Li K, Wang Q, Zhang L, Shi J, Wang Z, Cheng Y, He J, Shi Y, Zhao Y, Yu H, Zhao Y, Chen W, Luo Y, Wu L, Wang X, Pirker R, Nan K, Jin F, Dong J, Li B, Sun Y |
| Erscheinungsdaten | JAMA oncology. 2018 Aug 9. pii: 2696341. doi: 10.1001/jamaoncol.2018.3039 |
| Publikations ID | PMID: 30098152 |
| Is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer? | |
| Autoren | Pirker R |
| Erscheinungsdaten | ESMO open. 2018 Aug 10. doi: 10.1136/esmoopen-2018-000421. pii: esmoopen-2018-000421. pmc: PMC6088342 |
| Publikations ID | PMID: 30116594 |
| Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe. | |
| Autoren | Vrdoljak E, Bodoky G, Jassem J, Popescu R, Pirker R, Čufer T, Bešlija S, Eniu A, Todorović V, Kopečková K, Kurteva G, Tomašević Z, Sallaku A, Smichkoska S, Bajić Ž, Sikic B |
| Erscheinungsdaten | The oncologist. 2018 Sep 4. pii: theoncologist.2018-0093. doi: 10.1634/theoncologist.2018-0093 |
| Publikations ID | PMID: 30181313 |
| PD-1 and PD-L1 Protein Expression Predict Survival in Completely Resected Lung Adenocarcinoma. | |
| Autoren | Zaric B, Brcic L, Buder A, Brandstetter A, Buresch JO, Traint S, Kovacevic T, Stojsic V, Perin B, Pirker R, Filipits M |
| Erscheinungsdaten | Clinical lung cancer. 2018 Aug 22. pii: S1525-7304(18)30208-0. doi: 10.1016/j.cllc.2018.08.014 |
| Publikations ID | PMID: 30197262 |
| Treatment of Advanced Non-Small-Cell Lung Cancer: From Chemotherapy to Chemoimmunotherapy. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Journal of oncology practice. doi: 10.1200/JOP.18.00474 |
| Publikations ID | PMID: 30205773 |
| The role of ethnic tourism in the food knowledge tradition of Tyrolean migrants in Treze Tílias, SC, Brazil. | |
| Autoren | Kuhn E, Haselmair R, Pirker H, Vogl CR |
| Erscheinungsdaten | Journal of ethnobiology and ethnomedicine. 2018 Apr 6. doi: 10.1186/s13002-018-0224-9. pii: 10.1186/s13002-018-0224-9. pmc: PMC5889527 |
| Publikations ID | PMID: 29625616 |
| Adjuvant Therapy in Patients With Completely Resected Non-small-cell Lung Cancer: Current Status and Perspectives. | |
| Autoren | Pirker R, Filipits M |
| Erscheinungsdaten | Clinical lung cancer. 2018 Sep 24. pii: S1525-7304(18)30261-4. doi: 10.1016/j.cllc.2018.09.016 |
| Publikations ID | PMID: 30309777 |
| Management of stage IA -mutant adenocarcinoma of the lung. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Journal of thoracic disease. doi: 10.21037/jtd.2018.08.70. pii: jtd-10-S26-S3260. pmc: PMC6186648 |
| Publikations ID | PMID: 30370132 |
| LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer. | |
| Autoren | Seymour L, Le Teuff G, Brambilla E, Shepherd FA, Soria JC, Kratzke R, Graziano S, Douillard JY, Rosell R, Reiman A, Lacas B, Lueza B, Aviel-Ronen S, McLeer A, Le Chevalier T, Pirker R, Filipits M, Dunant A, Pignon JP, Tsao MS |
| Erscheinungsdaten | Clinical lung cancer. 2018 Oct 11. pii: S1525-7304(18)30262-6. doi: 10.1016/j.cllc.2018.10.001 |
| Publikations ID | PMID: 30414783 |
| Biomarkers for immune checkpoint inhibitors in advanced nonsmall cell lung cancer. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Current opinion in oncology. 2018 Nov 9. doi: 10.1097/CCO.0000000000000496 |
| Publikations ID | PMID: 30418192 |
| EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR. | |
| Autoren | Buder A, Setinek U, Hochmair MJ, Schwab S, Kirchbacher K, Keck A, Burghuber OC, Pirker R, Filipits M |
| Erscheinungsdaten | Targeted oncology. 2019 Feb 27. doi: 10.1007/s11523-019-00623-x. pii: 10.1007/s11523-019-00623-x |
| Publikations ID | PMID: 30810887 |
| Systemic therapy of elderly patients with advanced non-small cell lung cancer-individualized treatment is key. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Annals of translational medicine. doi: 10.21037/atm.2019.03.10. pii: atm-07-S1-S48. pmc: PMC6462625 |
| Publikations ID | PMID: 31032327 |
| From crizotinib to lorlatinib: continuous improvement in precision treatment of ALK-positive non-small cell lung cancer. | |
| Autoren | Pirker R, Filipits M |
| Erscheinungsdaten | ESMO open. 2019 Sep 8. doi: 10.1136/esmoopen-2019-000548. pii: esmoopen-2019-000548. pmc: PMC6735665 |
| Publikations ID | PMID: 31555485 |
| Chemotherapy remains a cornerstone in the treatment of nonsmall cell lung cancer. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Current opinion in oncology. 2019 Oct 9. doi: 10.1097/CCO.0000000000000592 |
| Publikations ID | PMID: 31599771 |
| Individualizing treatment of nonsmall cell lung cancer. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Current opinion in oncology. 2019 Oct 24. doi: 10.1097/CCO.0000000000000597 |
| Publikations ID | PMID: 31652144 |
| Presurgical epilepsy evaluation and epilepsy surgery. | |
| Autoren | Baumgartner C, Koren JP, Britto-Arias M, Zoche L, Pirker S |
| Erscheinungsdaten | F1000Research. 2019 Oct 29. doi: 10.12688/f1000research.17714.1. pmc: PMC6820825 |
| Publikations ID | PMID: 31700611 |
| Beyond tissue biopsy: a diagnostic framework to address tumor heterogeneity in lung cancer. | |
| Autoren | Voigt W, Manegold C, Pilz L, Wu YL, Müllauer L, Pirker R, Filipits M, Niklinski J, Petruzelka L, Prosch H |
| Erscheinungsdaten | Current opinion in oncology. 2019 Nov 9. doi: 10.1097/CCO.0000000000000598 |
| Publikations ID | PMID: 31714259 |
| Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses. | |
| Autoren | Pierceall WE, Olaussen KA, Rousseau V, Brambilla E, Sprott KM, Andre F, Pignon JP, Le Chevalier T, Pirker R, Jiang C, Filipits M, Chen Y, Kutok JL, Weaver DT, Ward BE, Soria JC |
| Erscheinungsdaten | Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Dec 4. pii: S0923-7534(19)35194-4. doi: 10.1093/annonc/mdr624 |
| Publikations ID | PMID: 32018692 |
| Third CECOG consensus on the systemic treatment of non-small-cell lung cancer. | |
| Autoren | Brodowicz T, Ciuleanu T, Crawford J, Filipits M, Fischer JR, Georgoulias V, Gridelli C, Hirsch FR, Jassem J, Kosmidis P, Krzakowski M, Manegold C, Pujol JL, Stahel R, Thatcher N, Vansteenkiste J, Minichsdorfer C, Zöchbauer-Müller S, Pirker R, Zielinski CC |
| Erscheinungsdaten | Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Dec 4. pii: S0923-7534(19)34677-0. doi: 10.1093/annonc/mdr381 |
| Publikations ID | PMID: 32018580 |
| Conquering lung cancer: current status and prospects for the future. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Pulmonology. 2020 Mar 18. pii: S2531-0437(20)30031-3. doi: 10.1016/j.pulmoe.2020.02.005 |
| Publikations ID | PMID: 32199906 |
| mutation tracking predicts survival in advanced -mutated non-small cell lung cancer patients treated with osimertinib. | |
| Autoren | Buder A, Hochmair MJ, Setinek U, Pirker R, Filipits M |
| Erscheinungsdaten | Translational lung cancer research. doi: 10.21037/tlcr.2020.03.02. pii: tlcr-09-02-239. pmc: PMC7225165 |
| Publikations ID | PMID: 32420063 |
| Care of patients with non-small-cell lung cancer stage III - the Central European real-world experience. | |
| Autoren | Zemanova M, Pirker R, Petruzelka L, Zbozínkova Z, Jovanovic D, Rajer M, Bogos K, Purkalne G, Ceriman V, Chaudhary S, Richter I, Kufa J, Jakubikova L, Zemaitis M, Cernovska M, Koubkova L, Vilasova Z, Dieckmann K, Farkas A, Spasic J, Fröhlich K, Tiefenbacher A, Hollosi V, Kultan J, Kolarová I, Votruba J |
| Erscheinungsdaten | Radiology and oncology. 2020 May 28. doi: 10.2478/raon-2020-0026. pii: /j/raon.2020.54.issue-2/raon-2020-0026/raon-2020-0026.xml |
| Publikations ID | PMID: 32463394 |
| ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy. | |
| Autoren | Besse B, Massard C, Haddad V, Andre F, Dunant A, Pirker R, Olaussen KA, Brambilla E, Fouret P, Soria JC |
| Erscheinungsdaten | Annals of oncology : official journal of the European Society for Medical Oncology. 2010 Aug 26. pii: S0923-7534(19)38607-7. doi: 10.1093/annonc/mdq407 |
| Publikations ID | PMID: 20801905 |
| Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses. | |
| Autoren | Pierceall WE, Olaussen KA, Rousseau V, Brambilla E, Sprott KM, Andre F, Pignon JP, Le Chevalier T, Pirker R, Jiang C, Filipits M, Chen Y, Kutok JL, Weaver DT, Ward BE, Soria JC |
| Erscheinungsdaten | Annals of oncology : official journal of the European Society for Medical Oncology. 2012 Jan 23. pii: S0923-7534(19)35194-4. doi: 10.1093/annonc/mdr624 |
| Publikations ID | PMID: 22269178 |
| Effects of CERA (continuous erythropoietin receptor activator) in patients with advanced non-small-cell lung cancer (NSCLC) receiving chemotherapy: results of a phase II study. | |
| Autoren | Gascon P, Pirker R, Del Mastro L, Durrwell L |
| Erscheinungsdaten | Annals of oncology : official journal of the European Society for Medical Oncology. 2010 Mar 24. pii: S0923-7534(19)39577-8. doi: 10.1093/annonc/mdq073 |
| Publikations ID | PMID: 20335369 |
| Immunotherapy combinations in advanced nonsmall cell lung cancer. | |
| Autoren | Pirker R |
| Erscheinungsdaten | Current opinion in oncology. 2020 Nov 11. doi: 10.1097/CCO.0000000000000700 |
| Publikations ID | PMID: 33186185 |
| The impact of hippocampal impairment on task-positive and task-negative language networks in temporal lobe epilepsy. | |
| Autoren | Nenning KH, Fösleitner O, Schwartz E, Schwarz M, Schmidbauer V, Geisl G, Widmann C, Pirker S, Baumgartner C, Prayer D, Pataraia E, Bartha-Doering L, Langs G, Kasprian G, Bonelli SB |
| Erscheinungsdaten | Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. 2020 Dec 3. pii: S1388-2457(20)30578-2. doi: 10.1016/j.clinph.2020.10.031 |
| Publikations ID | PMID: 33450563 |
| Lung Cancer in Austria. | |
| Autoren | Pirker R, Prosch H, Popper H, Klepetko W, Dieckmann K, Burghuber OC, Klikovits T, Hoda MA, Zöchbauer-Müller S, Filipits M |
| Erscheinungsdaten | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. pii: S1556-0864(20)31049-2. doi: 10.1016/j.jtho.2020.10.158 |
| Publikations ID | PMID: 33896572 |
| Lung cancer: continuous progress in diagnosis and treatment. | |
| Autoren | Pirker R, Zhou C |
| Erscheinungsdaten | Current opinion in oncology. 2021 Oct 27. doi: 10.1097/CCO.0000000000000809. pii: 00001622-900000000-98962 |
| Publikations ID | PMID: 34710885 |
| Increased expression of GABA receptor subunits associated with tonic inhibition in patients with temporal lobe epilepsy. | |
| Autoren | Sperk G, Pirker S, Gasser E, Wieselthaler A, Bukovac A, Kuchukhidze G, Maier H, Drexel M, Baumgartner C, Ortler M, Czech T |
| Erscheinungsdaten | Brain communications. 2021 Oct 12. doi: 10.1093/braincomms/fcab239. pii: fcab239. pmc: PMC8545616 |
| Publikations ID | PMID: 34708207 |
| Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study. | |
| Autoren | Domenighetti C, Sugier PE, Ashok Kumar Sreelatha A, Schulte C, Grover S, Mohamed O, Portugal B, May P, Bobbili DR, Radivojkov-Blagojevic M, Lichtner P, Singleton AB, Hernandez DG, Edsall C, Mellick GD, Zimprich A, Pirker W, Rogaeva E, Lang AE, Koks S, Taba P, Lesage S, Brice A, Corvol JC, Chartier-Harlin MC, Mutez E, Brockmann K, Deutschländer AB, Hadjigeorgiou GM, Dardiotis E, Stefanis L, Simitsi AM, Valente EM, Petrucci S, Duga S, Straniero L, Zecchinelli A, Pezzoli G, Brighina L, Ferrarese C, Annesi G, Quattrone A, Gagliardi M, Matsuo H, Kawamura Y, Hattori N, Nishioka K, Chung SJ, Kim YJ, Kolber P, van de Warrenburg BPC, Bloem BR, Aasly J, Toft M, Pihlstrøm L, Correia Guedes L, Ferreira JJ, Bardien S, Carr J, Tolosa E, Ezquerra M, Pastor P, Diez-Fairen M, Wirdefeldt K, Pedersen NL, Ran C, Belin AC, Puschmann A, Hellberg C, Clarke CE, Morrison KE, Tan M, Krainc D, Burbulla LF, Farrer MJ, Krüger R, Gasser T, Sharma M, Elbaz A |
| Erscheinungsdaten | Movement disorders : official journal of the Movement Disorder Society. 2022 Jan 8. doi: 10.1002/mds.28902 |
| Publikations ID | PMID: 34997937 |
| Anti-Neuronal IgG4 Autoimmune Diseases and IgG4-Related Diseases May Not Be Part of the Same Spectrum: A Comparative Study. | |
| Autoren | Endmayr V, Tunc C, Ergin L, De Rosa A, Weng R, Wagner L, Yu TY, Fichtenbaum A, Perkmann T, Haslacher H, Kozakowski N, Schwaiger C, Ricken G, Hametner S, Klotz S, Dutra LA, Lechner C, de Simoni D, Poppert KN, Müller GJ, Pirker S, Pirker W, Angelovski A, Valach M, Maestri M, Guida M, Ricciardi R, Frommlet F, Sieghart D, Pinter M, Kircher K, Artacker G, Höftberger R, Koneczny I |
| Erscheinungsdaten | Frontiers in immunology. 2022 Jan 14. doi: 10.3389/fimmu.2021.785247. pmc: PMC8795769 |
| Publikations ID | PMID: 35095860 |
| Imaging visuospatial memory in temporal lobe epilepsy-Results of an fMRI study. | |
| Autoren | Schmidbauer V, Nenning KH, Schwarz M, Foesleitner O, Mayr-Geisl G, Yildirim MS, Pirker S, Moser D, Denk D, Prayer D, Trimmel K, Langs G, Baumgartner C, Pataraia E, Kasprian G, Bonelli S |
| Erscheinungsdaten | PloS one. 2022 Feb 22. doi: 10.1371/journal.pone.0264349. pii: PONE-D-21-24949 |
| Publikations ID | PMID: 35192676 |
| The cancer survival index-A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies. | |
| Autoren | Gaiger A, Lubowitzki S, Krammer K, Zeilinger EL, Acel A, Cenic O, Schrott A, Unseld M, Rassoulian AP, Skrabs C, Valent P, Gisslinger H, Marosi C, Preusser M, Prager G, Kornek G, Pirker R, Steger GG, Bartsch R, Raderer M, Simonitsch-Klupp I, Thalhammer R, Zielinski C, Jäger U |
| Erscheinungsdaten | Cancer medicine. 2022 Mar 22. doi: 10.1002/cam4.4697 |
| Publikations ID | PMID: 35315594 |
| Automatic seizure detection and seizure pattern morphology. | |
| Autoren | Elezi L, Koren JP, Pirker S, Baumgartner C |
| Erscheinungsdaten | Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. 2022 Mar 18. pii: S1388-2457(22)00206-1. doi: 10.1016/j.clinph.2022.02.027 |
| Publikations ID | PMID: 35382982 |
| Genome-wide Association and Meta-analysis of Age-at-Onset in Parkinson Disease: Evidence From COURAGE-PD Consortium. | |
| Autoren | Grover S, Ashwin AKS, Pihlstrom L, Domenighetti C, Schulte C, Sugier PE, Radivojkov-Blagojevic M, Lichtner P, Mohamed O, Portugal B, Landoulsi Z, May P, Bobbili D, Edsall C, Bartusch F, Hanussek M, Krüger J, Hernandez DG, Blauwendraat C, Mellick GD, Zimprich A, Pirker W, Tan M, Rogaeva E, Lang A, Koks S, Taba P, Lesage S, Brice A, Corvol JC, Chartier-Harlin MC, Mutez E, Brockmann K, Deutschländer AB, Hadjigeorgiou GM, Dardiotis E, Stefanis L, Simitsi AM, Valente EM, Petrucci S, Straniero L, Zecchinelli A, Pezzoli G, Brighina L, Ferrarese C, Annesi G, Quattrone A, Gagliardi M, Burbulla LF, Matsuo H, Kawamura Y, Hattori N, Nishioka K, Chung SJ, Kim YJ, Pavelka L, van de Warrenburg BP, Bloem BR, Singleton AB, Aasly J, Toft M, Guedes LC, Ferreira JJ, Bardien S, Carr J, Tolosa E, Ezquerra M, Pastor P, Diez-Fairen M, Wirdefeldt K, Pedersen NL, Ran C, Belin AC, Puschmann A, Hellberg C, Clarke CE, Morrison KE, Krainc D, Farrer MJ, Kruger R, Elbaz A, Gasser T, Sharma M |
| Erscheinungsdaten | Neurology. 2022 May 26. pii: WNL.0000000000200699. doi: 10.1212/WNL.0000000000200699 |
| Publikations ID | PMID: 35618440 |
| The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited. | |
| Autoren | Domenighetti C, Douillard V, Sugier PE, Sreelatha AAK, Schulte C, Grover S, May P, Bobbili DR, Radivojkov-Blagojevic M, Lichtner P, Singleton AB, Hernandez DG, Edsall C, Gourraud PA, Mellick GD, Zimprich A, Pirker W, Rogaeva E, Lang AE, Koks S, Taba P, Lesage S, Brice A, Corvol JC, Chartier-Harlin MC, Mutez E, Brockmann K, Deutschländer AB, Hadjigeorgiou GM, Dardiotis E, Stefanis L, Simitsi AM, Valente EM, Petrucci S, Duga S, Straniero L, Zecchinelli A, Pezzoli G, Brighina L, Ferrarese C, Annesi G, Quattrone A, Gagliardi M, Matsuo H, Nakayama A, Hattori N, Nishioka K, Chung SJ, Kim YJ, Kolber P, van de Warrenburg BPC, Bloem BR, Aasly J, Toft M, Pihlstrøm L, Correia Guedes L, Ferreira JJ, Bardien S, Carr J, Tolosa E, Ezquerra M, Pastor P, Diez-Fairen M, Wirdefeldt K, Pedersen NL, Ran C, Belin AC, Puschmann A, Ygland Rödström E, Clarke CE, Morrison KE, Tan M, KraincMD D, Burbulla LF, Farrer MJ, Krüger R, Gasser T, Sharma M, Vince N, Elbaz A |
| Erscheinungsdaten | Movement disorders : official journal of the Movement Disorder Society. 2022 Jul 10. doi: 10.1002/mds.29133 |
| Publikations ID | PMID: 35810454 |
| Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease: Evidence From the COURAGE-PD Consortium. | |
| Autoren | Grover S, Kumar Sreelatha AA, Pihlstrom L, Domenighetti C, Schulte C, Sugier PE, Radivojkov-Blagojevic M, Lichtner P, Mohamed O, Portugal B, Landoulsi Z, May P, Bobbili D, Edsall C, Bartusch F, Hanussek M, Krüger J, Hernandez DG, Blauwendraat C, Mellick GD, Zimprich A, Pirker W, Tan M, Rogaeva E, Lang A, Koks S, Taba P, Lesage S, Brice A, Corvol JC, Chartier-Harlin MC, Mutez E, Brockmann K, Deutschländer AB, Hadjigeorgiou GM, Dardiotis E, Stefanis L, Simitsi AM, Valente EM, Petrucci S, Straniero L, Zecchinelli A, Pezzoli G, Brighina L, Ferrarese C, Annesi G, Quattrone A, Gagliardi M, Burbulla LF, Matsuo H, Kawamura Y, Hattori N, Nishioka K, Chung SJ, Kim YJ, Pavelka L, van de Warrenburg BPC, Bloem BR, Singleton AB, Aasly J, Toft M, Guedes LC, Ferreira JJ, Bardien S, Carr J, Tolosa E, Ezquerra M, Pastor P, Diez-Fairen M, Wirdefeldt K, Pedersen NL, Ran C, Belin AC, Puschmann A, Hellberg C, Clarke CE, Morrison KE, Krainc D, Farrer MJ, Kruger R, Elbaz A, Gasser T, Sharma M |
| Erscheinungsdaten | Neurology. 2022 May 26. pii: WNL.0000000000200699. doi: 10.1212/WNL.0000000000200699 |
| Publikations ID | PMID: 35970579 |
| Temporal Trends of Functional Outcome in Patients With Acute Ischemic Stroke Treated With Intravenous Thrombolysis. | |
| Autoren | Marko M, Miksova D, Ebner J, Lang M, Serles W, Sommer P, Sykora M, Lang W, Knoflach M, Kiechl S, Greisenegger S |
| Erscheinungsdaten | Stroke. 2022 Aug 24. doi: 10.1161/STROKEAHA.121.038400 |
| Publikations ID | PMID: 36000395 |
| Costs of Epilepsy in Austria: Unemployment as a primary driving factor. | |
| Autoren | Pirker S, Graef A, Gächter M, Baumgartner C |
| Erscheinungsdaten | Seizure. 2021 Apr 30. doi: 10.1016/j.seizure.2021.04.020. pii: S1059-1311(21)00137-0 |
| Publikations ID | PMID: 33975079 |
| Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers. | |
| Autoren | Sugier PE, Lucotte EA, Domenighetti C, Law MH, Iles MM, Brown K, Amos C, McKay JD, Hung RJ, Karimi M, Bacq-Daian D, Boland-Augé A, Olaso R, Deleuze JF, Lesueur F, Ostroumova E, Kesminiene A, de Vathaire F, Guénel P, Sreelatha AAK, Schulte C, Grover S, May P, Bobbili DR, Radivojkov-Blagojevic M, Lichtner P, Singleton AB, Hernandez DG, Edsall C, Mellick GD, Zimprich A, Pirker W, Rogaeva E, Lang AE, Koks S, Taba P, Lesage S, Brice A, Corvol JC, Chartier-Harlin MC, Mutez E, Brockmann K, Deutschländer AB, Hadjigeorgiou GM, Dardiotis E, Stefanis L, Simitsi AM, Valente EM, Petrucci S, Straniero L, Zecchinelli A, Pezzoli G, Brighina L, Ferrarese C, Annesi G, Quattrone A, Gagliardi M, Matsuo H, Nakayama A, Hattori N, Nishioka K, Chung SJ, Kim YJ, Kolber P, van de Warrenburg BPC, Bloem BR, Aasly J, Toft M, Pihlstrøm L, Guedes LC, Ferreira JJ, Bardien S, Carr J, Tolosa E, Ezquerra M, Pastor P, Diez-Fairen M, Wirdefeldt K, Pedersen N, Ran C, Belin AC, Puschmann A, Rödström EY, Clarke CE, Morrison KE, Tan M, Krainc D, Burbulla LF, Farrer MJ, Kruger R, Gasser T, Sharma M, Truong T, Elbaz A |
| Erscheinungsdaten | Movement disorders : official journal of the Movement Disorder Society. 2023 Feb 14. doi: 10.1002/mds.29337 |
| Publikations ID | PMID: 36788297 |
| Pharmacological Treatment of Tremor in Parkinson's Disease Revisited. | |
| Autoren | Pirker W, Katzenschlager R, Hallett M, Poewe W |
| Erscheinungsdaten | Journal of Parkinson's disease. 2023 Feb 21. doi: 10.3233/JPD-225060. pii: JPD225060 |
| Publikations ID | PMID: 36847017 |
| Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson's disease. | |
| Autoren | Gomes S, Garrido A, Tonelli F, Obiang D, Tolosa E, Martí MJ, Ruiz-Martínez J, Vinagre-Aragón A, Hernandez-Eguiazu H, Croitoru I, Marshall VL, Koenig T, Hotzy C, Hsieh F, Sakalosh M, Tengstrand E, Padmanabhan S, Merchant K, Bruecke C, Pirker W, Zimprich A, Sammler E |
| Erscheinungsdaten | NPJ Parkinson's disease. 2023 Apr 4. doi: 10.1038/s41531-023-00482-4. pii: 10.1038/s41531-023-00482-4 |
| Publikations ID | PMID: 37015928 |
| Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions. | |
| Autoren | Megyesfalvi Z, Gay CM, Popper H, Pirker R, Ostoros G, Heeke S, Lang C, Hoetzenecker K, Schwendenwein A, Boettiger K, Bunn PA, Renyi-Vamos F, Schelch K, Prosch H, Byers LA, Hirsch FR, Dome B |
| Erscheinungsdaten | CA: a cancer journal for clinicians. 2023 Jun 17. doi: 10.3322/caac.21785 |
| Publikations ID | PMID: 37329269 |
| Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease. | |
| Autoren | Berger-Sieczkowski E, Endmayr V, Haider C, Ricken G, Jauk P, Macher S, Pirker W, Högl B, Heidbreder A, Schnider P, Bradley-Zechmeister E, Mariotto S, Koneczny I, Reinecke R, Kasprian G, Weber C, Bergmann M, Milenkovic I, Berger T, Gaig C, Sabater L, Graus F, Gelpi E, Höftberger R |
| Erscheinungsdaten | Acta neuropathologica. 2023 Aug 30. doi: 10.1007/s00401-023-02625-6. pii: 10.1007/s00401-023-02625-6 |
| Publikations ID | PMID: 37646790 |